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ABSTRACT 
In the first part of this study, the kinetics of decay of 
TNP-nucleotide superfluorescence was investigated with a 
view to understanding the role of nucleotides and Lys492 in 
later steps in the catalytic cycle of the skeletal muscle 
Ca2+ATPase. It has been found previously, and verified here, 
that tethering TNP-8N3-AMP to the Ca
2+ATPase via Lys492 
retarded the Ca2+ initiated decay of Pi -induced 
superfluorescence 10-fold compared with untethered 
nucleotide. The rapidity of the decay upon addition of EDTA 
suggested that the E2 ~ E1 ~ E1Ca2 steps were being 
monitored rather than dephosphorylation per se. Tethered di-
and triphospho species did not accelerate the decay. While 
monophasic kinetics was observed with untethered TNP-AMP and 
TNP-8N3-AMP, complex kinetics were observed with the di- and 
triphospho TNP-nucleotides. This was shown to be due to the 
utilization of TNP-ADP and -ATP, and the azido derivatives, 
as coupled substrates of the Ca2+ATPase in the forward 
direction of catalysis in the presence of Ca2+. The 
hydrolysis rates of TNP-ADP, TNP-ATP, TNP-8N3-ADP, and 
TNP-8N3-ATP were 10, 5, 15 and 10 nomoles/min/mg of protein, 
respectively, at room temperature and pH 5.5. Ca2+ transport 
was supported by all four nucleotides. This is the first 
time that a diphosphonucleotide has been shown to support 
Ca2+ transport . A new nonhydrolysable triphospho TNP-
nucleotide, TNP-AMP-PCP was synthesized and shown to 
interact with the Ca2+ATPase in a similar way, in terms of 
superfluorescence, as the other TNP-nucleotides. It did not 
show the complex kinetics on inhibition of the Pcinduced 
superfluorescence by Ca2+, but neither did it accelerate the 
kinetics . It was concluded that TNP-nucleotides do not 
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accelerate the E2 ~ E1 transition under these conditions, 
possibly because of the presence of glycerol in the medium. 
In the second part of the study, it was shown that addition 
of small amounts of chelators EGTA, EDTA, BAPTA, DTPA, HEDTA 
and NTA to a Ca2+ transport assay in which the free Ca
2+ 
concentration is monitored by Fluo-3 causes the Ca
2+ATPase to 
pump to apparently lower levels as seen in the [Ca
2+] um 
fluorescence. Addition of chelator retards pump function in 
the sense that it takes longer for 50 nmols Ca
2+ to be 
accumulated. Increased thermodynamic efficiency of the pump 
and contaminating heavy metal ions were considered as 
possible mechanisms. To some extend Zn
2+ and Cd2 +, but not 
Fe2+ and Cu2+, appeared to reverse the partial inhibition. 
While interpretation of the results is difficult, it is 
suggested that heavy metal ions interact with luminal loops 
of the Ca2+ATPase and enhance Ca2 + release under conditions 
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1. INTRODUCTION 
1.1 Physiological role of SR 
Muscle contraction and relaxation is expedited by a 
system of membranes. The system consists of the 
plasmamembrane with its tubular infoldings (the T-system) 
running transversely to the fiber axis and a reticular 
structure (the sarcoplasmic reticulum, SR) that forms a 
network surrounding the myofibrils (see Fig 1) (Prescott, 
1988). Depolarization of the plasmamembrane is 
communicated by the T-system to the interior of the 
muscle fiber and Ca2+ is released from the SR to bind 
troponin located on thin filaments. 
and relaxation are induced by 
Muscle contraction 
the release and 
reabsorption of Ca2+ by SR. The T-system and SR are 
further interconnected in a structure called the triad. 
Biochemical studies are performed using fragmented SR 
isolated from muscle homogenates as vesicles. The pioneer 
work on the SR vesicles was performed by Hasselbach and 
Makinose (1961) and Ebashi and Lipmann (1962). They 
noticed that the isolated SR vesicles (SRV) could remove 
a significant amount of Ca2+ from the medium in the 
presence of ATP and Mg2+ . They also demonstrated that 
2 mol of Ca2+ were transported into the SRV when 1 mol of 
ATP was hydrolysed. Ca2+ATPase (EC 3. 6. 1. 3. 8) is a 
membranous enzyme found in the sarc'oplasmic reticulum 
vesicles, which is responsible for the transport of Ca
2+ 
from the reaction medium (or cytoplasm in muscle cells) 
into the lumen of the reticulum with ATP hydrolysis 
(MacLennan and Holland, 197 5) . In the relaxed state of 
the muscle, the free Ca2+ concentration is of the order of 
0 . 1 µM ( the limiting Ca2+ concentration, [Ca2+] lim ) , whereas 
the luminal free Ca2+ concentration is in the millimolar 
range (Hasselbach and Makinose, 1961, Ebashi and Lipmann, 
Figure 1 
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1962). The pump works against a 104-fold concentration 
gradient. 
1.2 General structure of Ca2 +ATPase 
There are three principal types of ATPases in which ATP 
hydrolysis is directly coupled to ion transport against 









Classes of ATPases 
Vacuolar type 
1) In the P-type of ATPases, an aspartic acid residue is 
phosphorylated during the transport process. From there 
the name, P-type. Included in this type, are the 
H+K+ATPase, Na+K+ATPase, K+H+ATPase, SERCA Ca2+ATPase, 
plasmamembrane Ca2+ATPase and Cu2+ transporting ATPase. In 
mammals the following subdivisions can also be made: 
Na+K+ATPase can be present in a.1, a.2 or the a.3 isoform. 
Four different isoforms of SERCA can be distinguished: 
SERCAl (found in fast-twitch skeletal muscle cells, adult 
and fetal isoforms have 997 and 1001 amino acid residues, 
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respectively) , SERCA2 (present in isoform 2a ( 997 amino 
acid residues) in cardiac and slow-twitch skeletal muscle 
cells; and in isoform 2b ( 102 4 amino acid residues) in 
many cell types) , SERCA3 ( found in platelets and other 
blood-forming cells, nonmuscle tissues eg. intestines, 
stomach, spleen and lungs). Plasmamembrane Ca
2+ATPase is 
present in four isoforms PMCAl, PMCA2, PMCA3 and PMCA4. 
The plasmamembrane Ca2+ATPase is bigger than the SERCA 
Ca2+ATPase, with 1080 to 1220 residues. 
2) The F1 F0-type is a proton transporting complex of 
several proteins found in eubacteria, chloroplasts and 
mitochondria and does not have a phospho-intermediate. 
3) Vacuolar type ( or V-type) is also a proton 
transporting complex of proteins and maintains the low pH 
of plant vacuoles and of lyzosomes and other vesicles in 
animal cells. 
The fast twitch rabbit skeletal Ca2+ATPase was used in our 
studies. It contains 997 amino acids and has a molecular 
weight of 110 kDa (MacLennan et al., 1985; Brandl et al., 
198 6) . A structural model of the Ca2+ATPase derived from 
the amino acid sequence is shown in Fig 2 (MacLennan et 
al., 1985; Brandl et al., 1986; Taylor and Green, 1989). 
The transmembrane segments and the extramembranous 
regions were identified from hydropathy plots (MacLennan 
et al., 1985). The proposed structure contains ten 
a-helical transmembrane segments and two large 
extramembranous cytoplasmic loops between membrane 
traverses M2 and M3 (termed the ~-strand domain) and M4 
and MS (the large cytoplasmic loop). Evidence that the 
phosphorylation site and ATP binding site are located on 
the latter, has mainly been provided by studies involving 
fluorescent and photoaffinity probes, such as Lys515 
labelling with FITC (Pick and Karlish, 1980; Pick and 
Bassilion, 1981; Mitchinson et al., 1982; Highsmith, 
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1986; Champeil et al., 
covalent labelling of 
(McIntosh et al., 1992; 
1988; Squier et 
Lys492 with 




al., 198 8) and 
probes (Murphy, 
and Woolley, 1994); 
1977; Yakamoto et 
intramolecular cross linking studies 
(Murphy, 1990; Ross et al., 1991; McIntosh et al., 1991) 
as well as site-directed mutagenesis (Marayuma et al., 
1989; Clarke et al., 1990; Vilsen et al. 1991). 
Figure 2 





D Transmembrane domain 
10 
The cytoplasmic loops are connected with the 
transmembrane segments by a 'stalk', consisting of 
amphiphatic a-helices. Previously it was thought that the 
stalk region contained the Ca2+ binding sites due to the 














































































































































residues in the first three helices (Brandl et al . , 1989; 
Green, 1989). However, it was later shown that the Ca2+ 
binding sites are located in the transmembrane sequences 
M4, MS, M6, M8 (MacLennan et al., 1985; Clarke et al . , 
1990) . Stalk sequences S4 and SS appear to communicate 
conformational changes initiated by nucleotide binding 
and phosphorylation down to the Ca2+ binding sites in the 
transmembrane domain, during Ca2+ transport (MacLennan et 
al., 1995, Andersen, 1995) . This accounts for the 
coupling between ATP hydrolysis and Ca2+ translocation 
(MacLennan, 1990; MacLennan et al . , 1992). Previously 
Highsmith and Murphy (1984) had found the closest 
distance between the ATP and Ca2+ binding sites to be 
between 21 and 26 A. However, more recent results, 
suggest that the distance is 35-40 A (Scott, 1985; Green 
and Stokes, 1992; Toyoshima et al . , 1993) . Toyoshima et 
al., 1993 have elucidated the tertiary structure of 
Ca2+ATPase at 14 A resolution, and Green and Stokes (1992) 
have suggested arrangements for the membrane helices 
(Fig 3 and 4) . These models support previous predictions 
that two large loops are located at the cytoplasmic side 
and 10 a-helices are located in the membrane . 
1.3 Catalyt ic cycle 
In order to facilitate the discussion of the catalytic 
cycle of Ca2+ATPase, a general reaction sequence, modified 
from McIntosh and Woolley (1994), will be used as 
reference . 
The Ca2+ATPase transports Ca2+ from the cytoplasm into the 
SR lumen and H+ in the opposite direction. The transport 
of Ca2+ is activated by phosphorylation with ATP, and that 
of H+ is associated with phosphoenzyme hydrolysis in the 
second part of the reaction cycle. The reaction cycle is 
initiated with the sequential binding of 2 Ca2+ to the E1H3 
6 
catalytic intermediate at the high affinity binding sites 
(Km - 1 µM) (Meissner, 1973; Dupont, 1982; Orlowski and 
Champeil; 1991) facing the cytoplasm and the dissociation 
of 2-3 H+ into the cytoplasm (de Meis and Vianna, 1979, 
Levy et al., 1990, Forge et al., 1993). Ca2+ binding (from 
the cytoplasm) at the transport sites is 
in the enzyme cycle, as it induces a 
a crucial step 
change in the 
chemical reactivity of the catalytic site, which is 
either phosphorylated by ATP ( in the forward direction) 
or by Pi (in the reverse direction) in the presence and 
absence of Ca2+, respectively. 
ElliJ 
2Ca2\ut 3H+ out 
~ 
ATP ADP 
~ <'-- _/) ( '-... L) IH E1 E1 - P 1 2 
6 3 
E rnJ 5 rn 4 ( 7" "4V E2 -P H (7 'V E-P~ z H 
~O H 
2 Ca 
p. 2Ca2+. 3H+in I ( m 
Phosphorylation by Pi and ATP, requires Mg2+ (Masuda and 
de Meis, 1973). The E1Ca2 form has a binding site for the 
catalytic Mg2+ ion with a Kct "' O. 94 rnM at pH 7. O, 25 °C 
(Punzengruber et al., 1978). This is approximately 
10-fold lower than that for the Ca2+-free enzyme, E1 , 
(8. 8 rnM) under similar conditions (Punzengruber et al., 
1978). Vianna (1975) previously suggested that the 
substrate in the forward direction of catalysis is MgATP. 
However, Reinstein and Jencks (1993) have found that the 
dissociation rate constants of ATP and Mg2+ from 
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E1Ca2ATP .Mg, 120 s-
1 and 60 s- 1 , respectively. This 
indicates that Mg2+ and ATP can bind and dissociate 
independently; they do not have to associate or 
dissociate from E1 as the MgATP complex. Incubation of 
free enzyme, E1 , with Mg
2+ and ATP, causes a 
conformational change that activates the enzyme for 
phosphorylation and decreases the rate constant for the 
dissociation of ATP to 47 s- 1 (Reinstein and Jencks, 
1993). In the reverse direction of catalysis Mg2+ and Pi 
bind separately (Punzengruber et al., 1978) or 
simultaneously (Champeil et al., 1985). De Meis et al 
(1991) presented data that the enzyme has different 
binding sites for Mg2+ and Pi . After MgATP binding to E1Ca2 
(Km 2 µM) (Meissner, 197 3) , the Ca2+ATPase is 
phosphorylated to give E1Ca2 P. The y-phosphate group of 
bound MgATP (Allen and Green, 1976) is transferred in a 
rapid reaction (rate constant ~ 1000 s-1 ) to the Asp351 
residue (Petithory and Jencks, 1986; Stahl and Jencks, 
1987), forming an acid-stable acylphosphate (Degani and 
Boyer, 1973). Synchronous with phosphorylation, the two 
bound Ca2+ become occluded, i.e. they are retained and 
unable to exchange with free Ca2+ in either aqeous phase 
(Dupont, 1982; Nakamura, 1987; McIntosh et al., 1991; 
Vil sen and Andersen, 1992) . The enzyme now undergoes a 
conformational change to E2Ca2 P, in which the Ca
2+ binding 
sites face the lumen of the SRV (Champeil et al., 1986; 
Wakabayashi and Shigekawa, 1990). In this conformation, 
the Ca2+ binding affinity is greatly reduced (Kct - 1 rnM) 
which permits the sequential dissociation of the 2 bound 
Ca2+ to the lumen. Yamaguchi and Kanazawa (1984, 1985) and 
Forge et al. (1993) have found that 2-3 H+ bind from the 
lumen to the E2 species. The phosphoenzyme is now 
dephosphorylated in a fast reaction to give E2 
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( ktorward = 60 s-1 ) ( Inesi et al., 1983; McIntosh and Boyer, 
1983) . The Ca2+ATPase recycles back to the E1H3 
conformation and a new reaction cycle can be initiated. 
1. 4 Energy coupling mechanisms 
Ca2+ATPase is an ion pump, which converts chemical energy 
into osmotic energy. In this case the input chemical 
energy is the free energy (~G) of ATP hydrolysis and the 
output osmotic energy is a 104-fold Ca2 + concentration 
gradient. Free energy transfer from ATP to the enzyme is 
facilitated through the phosphorylation reaction. This 
interconvertion of energy is made possible by coupled 
vectorial processes. 
It is important to notice that there are 




1) the relationship between changes in Gibbs energy for 
two processes, eg coupling of binding energies for two 
processes, or 
2) it is also used to describe the relationship between 
two processes, eg the hydrolysis of ATP that is coupled 
with the transport of Ca2+ (a coupled process) (Jencks, 
1982, 1992). 
First, attention will be given to coupling relating to 
the relationship between changes in Gibbs energy for two 
processes. The primary function of binding energy is 
kinetic, as 
species in 
it is utilized to avoid high- or low-energy 
the Ca2+ATPase catalytic cyle. High-energy 
species will possibly introduce a barrier to rapid enzyme 
turnover ( Fig SA) , whilst low-energy species will 
possibly cause the enzyme to fall into an energy pit, 
which will be difficult to escape from (Fig SB) . However, 
the energies of the catalytic species are balanced to 
avoid high- or low-energy species, i.e. the Gibbs 
9 
energies of all the species are similar (Wyman, 1964; 
Weber, 1975; Hill, 1977; Stein and Honig, 1977; Jencks, 
1980; Pickart and Jencks, 1984) (Fig SC). 
Figure 5 
Gibbs energy diagram 
A) Shows high-energy species and 
B) low-energy species along a reaction pathway, which 
cause barriers in the reaction cycle. 
C) Gibbs energy profile for Ca2+ATPase (pH 7.0, 8 rnM ATP, 
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Ca2+ATPase must overcome two thermodynamic barriers: 
1) In the forward direction of catalysis: the conversion 
of "low-energy" Ca2+ (bound at high-affinity sites, 
exposed to the cytoplasm) into "high-energy" Ca2+ (bound 
at low-affinity sites, exposed to lumen), and 
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2 ) In the reverse direction of catalysis: the conversion 
of the "low-energy" phosphate of E~P (which can be 
transferred to H2 0) into "high-energy" phosphate (which 
can only be transferred to ADP). These barriers are 
overcome by mutual destabilization of the occluded Ca2+ 
and covalently bound phosphate in E1Ca2P (Jencks, 1983; 
Pickart and Jencks, 1984). The spontaneous formation of 
the acyl phosphate species is driven by the intrinsic 
binding energy of phosphate alone, whilst the strong 
binding of two Ca2+ to the high affinity sites is driven 
by the intrinsic binding energy of Ca2+ alone (Jencks, 
1980; Hill and Eisenberg, 1981; Tanford, 1981 ) . When both 
Ca2+ and the phospho group are present in E1Ca2P, there is 
mutual destabilization of the ligands by 
~Go ~ 8 . 0 kcal / mol. This interaction energy i ncreases the 
escaping tendency of both Ca 2+ and the phosphate (Jenc ks, 
1983; Pickart and Jencks, 1984 ) . 
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On the other hand, the coupled process of ATP hydrolysis 
to Ca2+ transport is brought about by a set of rules. 
These rules generally represent the chemical specificity 
and vectorial specificity of the enzyme (Jencks, 1980, 
1992) and are based on known properties of different 
species of the enzyme in the catalytic cycle (de Meis and 
Vianna, 1979) Scheme 1 represents a simplified reaction 
cycle, that illustrates the set of coupling rules 
{Dupont, 1980; Jencks, 1982). 
Chemical specificity can be explained in the following 
manner: In order for the enzyme in state E1Ca2 to 
transport Ca2 + , it is neccesary for it to be 
phosphorylated by ATP. In the case of ATP synthesis in 
the reverse direction of catalysis, the enzyme in state 
E2Ca2P must be able to transfer the phosphate to ADP. As 
soon as Ca2+ is dissociated from the enzyme, its chemical 
specificity changes to catalysis of the phosphorylation 
of the enzyme by Pi and for transfer of the phosphate from 
E2P to water in the reverse direction. The vectorial 
specificity of the enzyme insures that in conformation E1, 
it will bind and dissociate Ca2+ only on the cytoplasmic 
side of the membrane, whereas the phosphorylated enzyme, 
E2P, will bind and dissociate Ca2+ only from to the lumen 
of the SRV. Thus 
the presence or 
chemical 
absence 
specificity is controlled by 
of bound Ca2+ . Vectorial 
specificity on the other hand, is controlled by enzyme 
phosphorylation: the unphosphorylated enzyme binds and 
dissociates Ca2+ only from the cytoplasm, whilst the 
phosphorylated enzyme, binds and dissociates Ca2+ only 
form the lumen. If this set of rules for chemical and 
vectorial specificity are followed, the chemical reaction 
of ATP hydrolysis is fully coupled to the translocation 
of two Ca2+ across the SR membrane. Violation of any of 
these rules, will lead to uncoupling of the system, i.e. 
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ATP will be hydrolysed and Ca2+ will not be transported or 
will leak out of the vesicles (Jencks, 1980, 1983). It is 
important to realise that there is not one specific step 
in the catalytic cycle that is responsible for coupling; 
failure of a coupling rule in any step will lead to 
uncoupling (Jencks, 1980; Hill and Eisenberg, 1981). 
1.5 _Regulation of the enzyme cycle by ATP 
Micromolar ATP is required for enzyme turnover, i.e. in 
this concentration range it has a catalytic function. 
However, ATP also has a regulatory function in the 
millimolar concentration range. It modulates the 
Ca2+ATPase catalytic cycle in a complex manner, so that it 
exhibits non-Michaelian kinetics with respect to ATP 
concentration (Inesi et al., 1967; Yamamoto and Tonomura, . 
1967; Dupont, 1977; Verjovski-Almieda and Inesi, 1979). 
ATP accelerates the steps associated with Ca2+ binding 
(E2 ~ E1 ~ E1Ca2) (Scofano et al., 1979; Guillain et al., 
1981; Champeil et al., 1983; Stahl and Jencks, 1984; 
Fernadez-Belda et al., 1984; 
Wakabayashi and Shigekawa., 
Wakabayashi et al., 1990; 
1990) , Ca2+ dissociation to 
the lumen (E2Ca2P -, E2P) ( Champeil and Guillain, 198 6; 
Wakabayashi et al., 1986) and phosphoenzyme hydrolysis 
(E2P -, E2) (Champeil et al., 1988; Mintz et al., 1990) . 
ATP accelerates therefore all the steps in the catalytic 
cycle, which start from a nucleotide-deprived species. 
Seebregts and McIntosh (1989) have found that low 
concentrations of TNP-8N3-ADP and -ATP accelerate ATPase 
acitivity -1.5-fold, showing that they bind to a 
regulatory site. The TNP-nucleotides label Lys492 at the 
catalytic site. It was concluded that the regulatory and 
catalytic site are at the same locus. This necessitates 
that regulation by ATP is due to the nucleotide 
reentering the active site after ADP dissociates. This is 
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supported by other structural and kinetic evidence (Ross 
and McIntosh, 1987; Champeil et al., 1988; McIntosh et 
al., 1992; Lacapere and Guillain, 1993) . It was suggested 
by Champeil and Guillain ( 198 6) and Champeil et al., 
(1988) that metal-free ATP is a more potent activator 
than MgATP for steps involving phosphoenzyme. In contrast 
to this model of ATP regulation, Coll and Murphy (1991) 
concluded that ATP accelerates phosphoenzyme hydrolysis, 
it must do so by binding to an allosteric site, because 
[y- 32 P] ATP formation was not inhibited when excess cold 
ATP was added to ADP and phosphoenzyme. Thus regulatory 
ATP does not appear to compete with ADP (i.e. at the 
phosphorylated active site). 
Whether ATP executes its regulatory function at the 
catalytic site or at another allosteric site, is still 
uncertain. So far, three models for the regulatory site 
location with one catalytic site per 110 kDa Ca2+ATPase 
chain, have been suggested: 
1) a dimeric functional unit in which only one subunit is 
phosphorylated and a "silent" nonphosphorylated catalytic 
site in a neighboring subunit, binds the regulatory ATP 
(Yates and Duance, 1976; Neet and Green, 1977; Silva and 
Verjovski-Almeida, 1979; Moller et al., 1980; McIntosh 
and Boyer, 1983); 
2) a second physically different nucleotide site per 110 
kDa chain, which binds the regulatory ATP, co-exists with 
the catalytic site (Coll and Murphy, 1984, 1985, 1991; 
Dupont et al., 1985; Suzuki et al., 1990, 1996), and 
3) a single nucleotide site per 110 kDa chain, with the 
regulatory nucleotide binding site overlapping with the 
catalytic site . Thus for the regulatory ATP to gain 
access to the site the nucleotide involved in 
phosphorylation (ATP or ADP) must have dissociated. 
(Andersen et al., 1982; McIntosh and Boyer, 1983; 
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Nakamoto and Inesi, 1984; Cable et al., 1985; Bishop et 
al., 1987; Ross and McIntosh, 1987; Champeil et al . , 
1988; Seebregts and McIntosh, 1989) 
ATP analogues, TNP-ADP and -ATP can also function in a 
regulatory role, but have been reported not to be 
hydrolysed (Watanabe and Inesi, 1982; Dupont et al., 
1985). TNP-ATP enhances ATP-mediated turnover (Dupont et 
al., 1985) and both TNP-ADP and -ATP accelerate 
phosphoenzyme hydrolysis (Champeil et al., 1988). TNP-8N3 -
ADP and -ATP activate ATP hydrolysis (Seebregts and 
McIntosh, 1989; McIntosh et al., 1992). This suggets that 
the nucleotide binding site may have different pockets, 
which could accomodate large substituents, so that 
regulation by these molecules are also possible. This 
will be discussed in the next section. 
1. 6 Structural charateristics of the ATP binding site 
Besides ATP, ITP (0 . 8), GTP (0.7), CTP (0.55) and UTP 
( 0 . 2 5) (numbers in parentheses represent velocities of 
hydrolysis relative to that of ATP) (Makinose and The, 
1965; Feirrera and Verjovski-Almeida, 1988), TNP-8N3-ATP 
(McIntosh and Woolley, 1994), p-nitrophenyl phosphate 
(Inesi, 1971) and acetyl phosphate (de Meis, 1969; de 
Meis and Hasselbach, 1971; Pucell and Martonosi, 1971; 
Bodley and Jencks, 1987), carbamyl phosphate (Pucell and 
Martonosi, 1971) can also serve as substrates . Active Ca2+ 
transport is supported by all these compounds and the 
coupling of 2 mol of Ca2+ for each mol of Pi liberated, is 
maintained (Makinose and The, 1965; Friedman and 
Makinose, 1970; Inesi, 1971). 
Anderson and Murphy (1983) found that both the catalytic 
(high affinity) and the regulatory ( low affinity) site 
are more tolerant to changes in the 2' OH of the ribose 
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compared with 3' OH. The hydroxyl groups appear to be 
involved in stabilizing the enzyme nucleotide complex 
(Coan et al., 1993). It appears that the catalytic and 
regulatory substrate specificity of Ca2+ATPase appears is 
low, suggesting that the nucleotide binding site 
accommodates many different shaped molecules by utilizing 
different binding pockets lining the site. 
Approaches such as chemical modification, photolabeling 
and site-directed mutagenesis of amino acids are used to 
delineate the ATP binding site. Some amino acids are 
found to be involved in complexing both catalytic ATP or 
regulatory ATP and others one or the other nucleotide. So 
far Thr532 and Thr 533 (Lacapere et al., 1993); Arg678 
(McIntosh, 1992) ; Lys 68 4 (Yamamoto et al., 198 9) ; Lys4 92 
(McIntosh et al., 1992; McIntosh, 1992; Stefanova et al., 
1993; Yamagata et al., 1994; Yamasaki et al., 1994); and 
Lys515 (Mitchinson et al., 1982) have been identified to 
ligate the catalytic ATP. The latter two amino acids were 
also found to aid in binding regulatory ATP on the 
phosphorylated enzyme . The role of Lys492 in ligating ATP 
is quite complex. Lys492 labelling with 7-amino-4-
methylcoumarin-3-acetic acid succinidyl ester had no 
effect on ATPase activity (Stefanova et al., 1989), but 
labeling with or TNP-8N3-ATP, resulted in the partial 
uncoupling of the enzyme (McIntosh and Woolley, 1994) . 
Glutaraldehyde crosslinking of Lys492 to Arg678 allowed 
ATP-dependent Ca2+ occlusion and completely blocked Ca2+ 
dissociation to the lumen (McIntosh et al . , 1991). 
Site-directed mutagenesis pointed out that the ligating 
role Lys515 is also complex. Mutation of Lys515 led to a 
lowered Ca2+ transport activity, because of weaker ATP 
binding (Maruyama et al . , 1988). Later it was found that 
mutation of Lys515 also led to complete inhibition of 
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ATP- and acetyl phosphate facilitated Ca2+ transport. 
McIntosh et al. (1996) found through mutation studies on 
the segment 487 FSRDRK492 and labeling with TNP-8N3 -ATP, that 
Lys492 does play a role in ATP binding, but is not 
essential for enzyme turnover. Phe487 was also indicated 
in playing an important role in ATP ligation, and to a 
lesser extent Arg489. They also found that these three 
residues were binding catalytic and regulatory ATP. ATP 
blocked the intramolecular glutaraldehyde crosslink with 
mutation of Lys684 (located in the hinge domain), 
indicating that it does not play a crucial role in 
nucleotide binding (Vilsen et al., 1991) . ATP did not 
inhibit the glutaraldehyde crosslink in the mutated D601 
to E601 enzyme (MacLennan et al., 1992) . The cross link 
was also not inhibited by mutating P603 to G603. This 
implies that the conserved 601 DPPR segment plays an 
important role in complexing ATP. 
Chemical modification and photolabeling of amino acids 
with chromophoric probes not only provide insights into 
amino acid residues which ligate ATP, but also indicate 
the microenvironment (eg. hydrophobicity) of the site. 
The ATP binding site need not be rigid, and with each 
step in the catalytic cycle, the amino acid residues that 
constitute the site, could rearrange so that the 
configuration, polarity of the site, and pKa of amino acid 
residues as well as their reactivity are changed. The 
interactions between residues complexing catalytic ATP 
must be different from those binding regulatory ATP. 
Changes in nucleotide binding affinity, reactivity of 
residues, and polarity of the site have been detected by 
probes (Pick and Karlish, 1980; Ross and McIntosh, 1987; 
Wakabayashi et al., 1990; Wakabayashi and Shigekawa, 
1990; Lacapere and Guillain, 1990 and 1993; DeJesus et 
al., 1993). The TNP-nucleotides provide a good example of 
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how the polarity of the nucleotide binding site changes. 
The transition from the ADP-sensitive phosphoenzyme 
(E1PCa2 ) to one which is insensitive to ADP (E2 PCa2 ) is 
accompanied by a conformational change at the active site 
as can be seen from the interaction of TNP-nucleotides. 
The TNP-nucleotides display a large increase in 
fluorescence or superfluorescence either during ATP-
mediated turnover in the forward direction of catalysis 
or in the reverse direction following phosphorylation by 
Pi in the absence of Ca2+ (Watanabe and Inesi, 1982; 
Nakamoto and Inesi, 1984; Davidson and Berman, 1987). 
Dupont and Pougeois (1983) found the polarity of the free 
catalytic site to be lower than that of water and a 
further large· decrease is observed when Ca2+ATPase is 
phosphorylated by P1 • Phosphorylation to E2P must increase 
the hydrophobicity around the TNP-moiety. The fluorescent 
FITC probe which labels Lys515 and the crosslinking of 
Lys492 and Arg678 with glutaraldehyde, also provide 
evidence of the changes in the microenvironment of the 
nucleotide binding site during the catalytic cycle. The 
E1Ca2P to E2 P transition induce a large increase in FITC 
fluorescence, indicating a change to a more hydrophobic 
environment (Pick, 1981). Enzyme phosphorylation by Pi to 
give E2 P completely inhibits the glutaraldehyde cross-
linking of Lys492 and Arg678 (Ross and McIntosh, 1987). 
Of the 2 4 Cys residues which react with SH reagents, 9 
are protected by ATP binding (Mahaney et al., 1995; 
Wawrynow and Collins, 1993). Since the cysteine residues 
are not conserved, the change in reactivity may be due 
entirely to conformational changes as a result of 
nucleotide binding. 
1. 7 Ca2 + binding sites 
1.7.1 Structural characteristics 
It was originally considered that the 
transport sites for Ca2+ may be located 
high affinity 
in the stalk 
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region due to the presence of 16 negatively charged 
glutamic acid residues in the first three helices (Brandl 
et al., 1986; 
mutagenesis has 
Green, 1989). However, 
identified Glu309 in 
site-specific 
transmernbrane 
sequence M4, Glu771 in MS, Asn796, Thr799 and Asp800 in 
M6 and Glu908 in MS to be involved in Ca2+ binding (Brandl 
et al., 1989; MacLennan et al., 1985; Clarke et al., 
1989, 1990). Andersen (1995) provided evidence from site-
directed mutagenesis that Glu309 and Asn796 are 
associated with one Ca2+ binding site, Glu771 and Thr799 
with another site and Asp800 with both sites. According 
to Andersen and Vilsen (1996) Glu908 does not bind Ca2+ 
directly in the occluded state and Asn796 is possibly 
involved in the counter transport of H+. Rice and 
MacLennan (1996) showed by mutagenesis studies that tiers 
3, 4 and 5 of M4, MS and M6 contain Ca2+ binding and 
affinity mutations (Fig 6). 
Figure 6 








M4 MS M6 MS 
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These central tiers are also 
conformational 
apparently has 
changes involved in 
a peripheral role 
implicated in 
Ca2+ transport. 




translocation in comparison to M4, M5 and M6, as 
mutations in MS failed to identify residues involved in 
blocking conformational changes or altering Ca2+ affinity. 
Transmembrane segment M7 is considered to be obliquely 
angled with respect to the axis normal to the mebrane 
(Stokes and Green, 1994). Chen et al. (1996) identified 
short and long range roles of several amino acids within 
the transmembrane sequences, by site-directed mutagenesis 
and by modelling. Some of the short range roles include 
the direct involvement of Glu309, Glu771, Thr799, Asp800, 
Glu908 and Asn796 in M4, M5, M6 and MS, to form a Ca2+ 
binding channel; roles of several residues in the 
stabilization of the helical cluster for optimal channel 
function and Lys297 which seals the distal end of the Ca2+ 
binding channel. 
involvement of 
Long range roles include the possible 
several transmembrane residues in the 
communication between the Ca2+ binding sites and 
phosphorylation and ATP binding sites, for example, 
transmembrane helix M4 may rotate to allow vectorial flux 
of Ca2+ after enzyme phosphorylation by ATP. 
1. 7. 2 Ca2 + binding kinetics 
Ca2+ binding kinetics can be monitored by 45Ca2+ and 
filtration or indirectly by Ca2+ATPase intrinsic 
tryptophan fluorescence (Dupont and Leigh, 1978; Guillain 
et al., 1980, 1981; Verjovski-Almeida and Silva, 1981; 
Champeil et al., 1983; Fernandez-Belda et al., 1984; 
Scofano et al., 1985; Moutin and Dupont, 1991) or 
labelling an amino acid with a fluorescent sensitive 
probe near the Ca2+ binding sites, such as DMC which 
labels Cys344 ( Stefanova et al., 1992) or NBD-labelled 
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Ca2+ATPase which moni tores the E2 f-, E1 equilibrium 
(Henderson et al., 1994). 
Ca2+ binding is apparently cooperative, suggesting a 
mechanism such as that shown in Scheme 2 (Dupont, 1976; 
Ikemoto et al., 1978; Dupont and Leigh, 1978; Guillain et 
al., 1980; Inesi et al., 1980; Champeil et al., 1983; 
Gould et al., 1986; Froud and Lee, 1986; Inesi, 1987). 
Scheme 2 
The value of the E2 f-, E1 equilibrium constant has been 
estimated as 0 .5 at pH 7.2 (Froud and Lee, 1986). If Ca2+ 
binding is not cooperative the E2 f-, E1 equilibrium 
constant would have been less than O. 01 if the two Ca2+ 
binding sites were of equal affinity (i.e. K1 = K2 in 
Scheme 2) (Inesi, 1987). Suen a low value for the E2 f-, E1 
equilibrium constant seems to be inconsistent with values 
obtained by Pick (1982) and Froud and Lee (1986). The 
cooperativity of Ca2+ binding can be explained if the 
first, inner site has a higher affinity for Ca2+ than the 
outer site (i.e. K2 >Ki). 
Ca2+ binds sequentially; first to the inner, high affinity 
binding site exposed to the cytoplasm. A second, outer 
Ca2+ binding site is formed after Ca2+ binding of the first 
inner Ca2+. The apparent binding constant for the first, 
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inner Ca2+ is lower compared with the outer Ca2+ (Dupont, 
1982; Orlowski and Champeil, 1991), which is in agreement 
with the cooperative binding model. Dupont (1982) and 
Nakamura (1986) found that cytoplasmic dissociation of 
Ca2+ from the unphosphorylated enzyme is biphasic in the 
presence of excess 4°Ca2 +. This is evidence that Ca2+ 
dissociation is sequential. Nakamura (1986) also found 
sequential dissociation of Ca2+ from the phosphorylated 
enzyme. Ikemoto et al. (1981), Inesi (1987), Moutin and 
Dupont (1991) and Orlowski and Champeil (1991) also 
support this mechanism of sequential dissociation on 
cytoplasmic side. Forge et al. (1995) found the 
dissociation rates in excess EGTA and Mg2+ (pH 8, 5 QC), 
to be 20 s-1 and 1 s-1 for the superficial and inner Ca2+, 
respectively, and excess 4°Ca2+ blocks release of the inner 
45Ca2+ and leads to half of 45Ca2+ being dissociated, with 
rate constant of 9 s-1 (pH 8, 5 QC). 
Ca2+ binding kinetics is sensitive to Mg2+ and H+ concen-
trations, and is modulated by millimolar ATP concen-
trations (see section 3.5). Mg2+ appears to compete with 
Ca2+ for binding at the Ca2+ sites ( cytoplasmic on E1 and 
luminal on E2P) (Guillain et al., 1982; Froud and Lee, 
1986; Gould et al., 1986; Bishop and Al-Shawi, 1988). 
This binding is in competition with H+ binding 
(Michelangeli et al., 1990; Forge et al., 1993). Mg2+ also 
effects Ca2+ dissociation from the unphosphorylated 
enzyme, implying that Mg2+ can also bind to site(s) other 
than at the Ca2+ binding sites (Moutin and Dupont, 1991). 
Henderson et al. ( 1994) have found that the Kct of Mg2+ is 
pH-independent in the presence or absence of Ca2+ (Kd - 2 
rnM). From this the following scheme was proposed for Mg2+ 
and H+ binding (Henderson et al., 1994): 
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Scheme 3 
Hendersen et al. (1994) 
E1HMg ~ E1CaHMg 
Mg''-i 1 "'- Mg'' 
E1H ~ E1CaH 
H' ~1 1~ H+ 
E1 ~ E1Ca 
Mg''-{ YMg'' 
E1Mg ~ E1CaMg 
Forge et al . ( 1993) has described the inhibition effects 
by H+ and Mg2+ on Ca2+ binding in the following manner. 
Inhibition by H+ i s described by two steps involving two 
H+ and one H+, with pK 7 and 7.9, respectively. At pH 6.0, 
two ff" must dissociate to bind the first inner Ca2+ and a 
third H+ for the second superficial Ca2+. At pH 9, both 
Ca2+ bind without any H+ exchange. Mg2+ on the other hand, 
can bind to all the species, except to the saturated Ca2+ 
species. Mg2+ binds tighter to the species having lost two 
H+ (~ 1 mM) than to the species having three H+ ( 4 mM) • 
The deprotonated form (Ei) not only has a higher affinity 
for Ca2+, but also binds Ca2+ faster than the protonated 
form (E2 ), k > 50 s-1 and 1. 3-2. 7 s-1, respectively ( Forge 
et al., 1993). Martin et al. (1992) has found that both 
Ca2+ and H+ bind cooperatively at the Ca2+ binding sites. 
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Scheme 4 










The equilibrium stability product for the two Ca
2+ binding 
of l og K1K2 = 13. 2 decreases to 11. 9 at pH 6. 8, due to 
competition from protons. At pH less than 7.6, the 
l · f h ld two H+ at the Ca
2+ ca cium ree enzyme o s sites. 
Henderson et al. ( 1994) proposed that the pH and Mg
2+ 
effect on Ca2+ binding is due to the their binding to a 
'gating' site at the Ca2+ sites, which affects the 
affinity of the first Ca2+ binding site for Ca
2+ and the 
rate of Ca2+ dissociation (see Fig 7). 
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Fig 7 
Binding of Mg2+, H+ and ca2 • 




It was found by Jencks (1975, 1980 ) that both Ca2+ must 
bind before the enzyme cycle can be activated by ATP 
phosphorylation. Upon phosphorylation of the enzyme, the 
two Ca2+ become occluded, and cannot leave the sites 
(Dupont, 1982 ) . Vilsen and Andersen (1992) also provided · 
evidence consistent with the existence of two 
nonequivalent and interdependent Ca2 + occlusion sites. 
CrATP was used as a substrate, that stabilizes a form of 
the enzyme containing both Ca2 + ions in an occluded state, 
without enzyme phosphorylation, but perhaps mimicking the 
E1 P state. The dissociation rate constant for the first, 
superficial Ca2+ and inner Ca2 + was O. 99 h-1 and O. 25 h-1 , 
respectively. When the first site was still occupied by 
Ca2+ , the second, inner Ca2+ dissociated with a rate 
constant of O .13 h-1 • 
Inesi ( 1987) provided evidence that the first Ca2+ bound 
on the cytoplasmic side is released first to the lumen 
( Fig 8) . It required setting up a pre-built order of 45Ca2 + 
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or 4°Ca2+ in the unphosphorylated ATPase and then adding 
ATP. 
Figure 8 






Hanel and Jencks (1991 ) and Orlowski and 
(1991) could not distinguised between 
dissociation of the two Ca2+ into the lumen. Later work 
indicated that under select conditions (5 °C, pH 8.0, 
300 rnM KCl ) there is sequential dissociation to the 
lumen, since 4°Ca2+ slowed the release of the inner Ca2+ 
(Forge et al., 1993). Canet et al. (1996) have further 
provided evidence that the Ca2+ are randomized during 
translocation , i.e. a prebuilt ca2+ order is not 
maintained during membrane translocation of the two Ca2+ 
ions. This could indicate more than two sets of Ca2+ 
binding sites, which would be compatable with the results 
of Meszaros and Bak (1992, 1993), Jencks et al. (1993) 
and Myung and Jencks (1994). They proposed there are four 
Ca2+ binding sites on the Ca2+ATPase in a single channel 
( Fig 9A) . Martonosi ( 1995) proposed a model accounting 
for four possible sites with two channels. (Fig 9B). 
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Figure 9 





The enzyme undergoes a transition to the E2 conformation, 
in which case the Ca2+ binding sites face the lumen and 
Ca2+ affinity is greatly reduced. Both Ca2+ must dissociate 
to the lumen before phosphoenzyme hydrolysis (E2P ~ E2 ) 
can take place (Khananshvili and Jencks, 1988). De Meis 
(1981) postulated in the original catalytic cycle, that 
all E2 states (phosphorylated or unphosphoryated) were 
able to bind Ca2+ at two low affinity sites. However, 
Peti thory and Jencks ( 1988) provided evidence that the 
unphosphorylated E2 state cannot bind Ca2+ . Forge et al., 
(1995) have found that the Ca2+ transport sites of the 
nonphosphorylated and phosphorylated enzymes show a close 
similarity, although the orientation, affinities and 
dissociation are different, in agreement with de Meis 
(1981) . Khan et al. (1997) support de Meis (1981), as 
they have found that Ca2 + (on the luminal side) can bind 
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to both E 2 (unphosphorylated) or E 2 P (phosphorylated) 
intermediates with similar binding affinities. 
1.7.3 Chemical properties of Ca2 + 
Calcium and magnesium belong to the IIA(2) 
elements and are alkaline earth metal ions. 
group of 
They lack 
easily excitable unshared valence electrons, and are 
classified as 'hard' (Cotton and Wilkinson, 1972) . They 
therefore tend to bind to 'hard' ligands, especially 
those containing oxygen atoms, and less readily to 
nitrogen atoms and very rarely to 'soft' sulfur atoms. 
Ca2+ binds ligands with intermediate strength and this 
makes it useful in control of conformational changes and 
cell activities (Martin, 1984). Ca2+ can bind to a large 
number of centres simulataneously. This ability is not 
shared by Mg2+ or Zn2+ . These factors give Ca2+ a selective 
binding chemistry. Zinc belongs to the IIB ( 12) group of 
elements. These elements form no compound in which the d 
shell is other than full, so they are regarded as non-
transition elements. The metals in this group are 
'softer' than the the transition metals. Zn2+ is less 
electroposi ti ve than Ca2+ and Mg2+ . Mg2+ , Ca2+ and Zn2+ have 
different sizes, with ionic radii and charge-to-radius 
ratios of 0.65, 0.99 and 0.69 and 3.1, 2.0 and 2.9 
respectively (Cotton and Wilkinson, 1972). The 
coordination number is the number of liganding atoms that 
can pack around the cation in the first coordination 
sphere. The average coordination number of Mg2+ and Ca2+ 
ions are 6.0 and 7.3 respectively (Cotton and Wilkinson). 
Zn2+ bind to ligands with coordination numbers 4,5 and 6, 
with 5 especially common. The metal-oxygen distance for 
Mg2+ and Ca2+ are 1. 95 and 2. 23+ respectively (Cotton and 
Wilkinson) . 
Ca2+ and Mg2+ bind to proteins mainly by carboxylate 
groups, such as aspartate and glutamate. Zn2+ , which is a 
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'softer' ion compared with Mg2+ and Ca2+, binds to cysteine 
and histidine via the 'softer' sulphur and nitrogen atoms 
respectively, and also to aspartate and glutamate via the 
'harder' oxygen. Mg2+ and Ca2+ bind only in the plane of 
the carboxyl group. Ca2+ shares the two oxygen atoms of 
the carboxylic group equally, a characteristic that is 
not shared with Mg2 +. Mg2+ binding to ligands is invariably 
octahedral and more rigid. Ca2+ display more variable 
coordination and flexibility in the geometry of ligand 
binding, compared to Mg2+. This geometry is is controlled 
by the first sphere, second coordination sphere and 
solvation of Ca2+ in solution. Ca2+ and Mg2+ kinetics 
differ in two aspects. Ca2+ exchanges water at close to 
the collisional diffusion limit of 1010 s-
1 and its 
reaction on-rates are often diffusion-limited, whereas 
its off-rates are limited by binding strength. Mg
2+ and 
Zn2+ exchange water with rate constants close to 10
6 and 
107 s-1 , respectively (Cotton and Wilkinson). Proteins 
bind cations with strengths that depend on the size and 
charge of the cation. The higher the charge, the stronger 
it binds. The size is also important and the protein 
often provide a pocket of the correct size to bind the 
cation and it can therefore distinguish between different 
cations. 
1. 8 ATP analogues 
1.8.1 Structure, stereochemistry and charateristics 
of ATP analogues 
In order to elucidate the roles of the adenine, ribose 
and triphosphate moieties in the catalytic and regulatory 
function of ATP in the Ca2+ATPase cycle and other ATP-
utilizing enzymes, many ATP analogues have been 
synthesized (Ikehora et al., 1961; Miller and Westheimer, 
1966; Lecoeq, 1968). The ribose moiety has been 
implicated in hydrogen binding for many nucleotide 
binding enzymes (Banks et al., 1979; Branden et al., 
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1975; Moras et al., 1975; Holbrook et al., 1975). In the 
case of the Ca2+ATPase, Anderson and Murphy (1983) have 
found that neither the catalytic (high affinity) nor the 
regulatory ( low affinity) site tolerates changes in the 
hydroxyl subs ti tuent at the 3 'OH of the ribose ring of 
ATP, whereas steady state rates associated with substrate 
binding at both sites are less affected by changes at the 
2'0H position. Weaker substrate binding in the absence of 
a ribose hydroxyl, was also observed. They also suggested 
that the hydroxyls are important for substrate alignment, 
i.e. optimal positioning of the y-phosphoryl group with 
respect to Asp351. Clore et al. (1982) have shown from 
NMR measurements, that binding of ATP to either the 
catalytic or regulatory site(s), produces conformational 
changes of the ribose moiety. The free nucleotide's 
predominantly 2'endo conformation of the S type is 
changed to a 3' endo conformation of the N type and the 
gauche-gauche conformation about the C4' and C5' bond is 
changed to gauche-trans or trans-gauche. 
Photoaffini ty analogues have been used to identify and 
characterize nucleotide binding sites (Bayley and 
Knowles, 1977; Chowdry and Westheimer, 1979; Guillory, 
1979). The 8-azidopurine derivatives (Haley, 1974, 1975) 
and 3'-ribose-coupled arylazides (Jeng and Guillory, 
1975; Lunardi et al., 1977), have been mostly used. 
Substitution at the purine C-8 position represents a 
small structural change, but probably shifts the 
nucleotide's configuration about the N-glycosidic linkage 
from anti to syn (Tavale and Sobell, 1970; Ikehara et 
al., 1972; Sarma et al., 1974). The TNP-nucleotides are 
analogues of ATP, which have an environmentally sensitive 
chromophore or fluorophore group to provide information 
about the microenvironment within the ATP binding site 
(Murphy and Morales, 1970; Onodera and Yogi, 1971). The 
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visible absorption characteristics of the TNP-nucleotides 
are that of a typical Meissenheimer compound linking 
2 '0H and 3'0H groups and trinitrocyclohexyldienylidine 
with absorption maxima at 259 nm, 408 nm and 470 nm at 
neutral pH. (Foster et al., 1965; Murto, 1965, Hiratsuka 
and Uchida, 1973). The Meissenheimer complex of the TNP-
ribose linkage exhibits a pKa of 5.1 (Hiratsuka, 1975). 
Ah-Kow et al., 1980 had found that at acidic pH the 
opening of the dioxolane ring of the TNP-nucleotide 
occurred at the 2'-oxygen to yield a 3'-0- (2,4 , 6-
trinitrophenyl) derivative as the only product. 
Scheme 5 
Structure of TNP-nucleotides at neutral or acidic pH 
values 
Neutral or alkaline pH Acidic pH 
+ tt· 
3'-0- (2,4,6-trinitrophenyl) derivative 
ATP binds to Ca2+ATPase with binding affinity ~ = 2 µM 
(Meissner, 1973). TNP-AMP, -ADP and -ATP bind tighter to 
the enzyme with binding affinities 7. 62 nM ( Suzuki et 
al., 1990), 50-150 nM (Dupont et al., 1982) and 200 nM 
(Dupont et al., 1982) , respectively. They probably 
exhibit an anti conformation about the glycosidic bond. 
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Their 8-azido derivatives were synthesized by Seebregts 
and McIntosh (1989) and probably exhibit a syn 
conformation (Tavale and Sobell; 1970; Ikehara et al . , 
1972; Sarma et al., 1974; McIntosh and Woolley, 1994) and 
have absorbance maxima at 281 nm ( 8-N3-moiety), 408 and 
468 nm (both TNP-moiety) (Seebregts and McIntosh, 1989) . 
TNP-8N3-AMP, -ADP and -ATP bind tighter than ATP to 
Ca2+ATPase, but less tightly than the nonazido 
nucleotides, with binding affinity Kct = 0.04-0 . 4 µM 
(Seebregts and McIntosh, 1989) . Irradiation at alkaline 
pH results in specific covalent incorporation of the 
8-azido TNP-nucleotides onto Lys492 . In the same 
concentration range, they all undergo a large increase in 
fluorescence (so-called superfluorescence) (Watanabe and 
Inesi, 1982; Nakamoto and Inesi, 1984; Bishop et al . , 
1984, 1986; Davidson and Berman, 1987) during enzyme 
turnover in the presence of ATP and Ca2 , or 
phosphorylation from Pi in a Ca2-depleted medium which has 
been ascribed to binding to the E2P catalytic intermediate 
(Davidson and Berman, 1987; Wakabayashi et al., 1986) . 
1.8.2 Synthesis of nonhydrolyzable ATP analogues 
ATP plays a major important role in biological systems . 
Yet our understanding of its interactions with enzymes as 
both a substrate and as a regulator is incomplete and 
unsatisfactory . Analogues of ATP with modified 
triphosphate chains, have been synthesized to better 
understand these interactions. To analyze the effect of a 
nucleotide on the phosphoenzyme hydrolysis reaction, the 
use of nonhydrolysable ATP analogues is more convenient 
as it avoids perturbing the phosphoenzyme hydrolysis 
(E2 P ---+ E2 ) reaction by the enzyme cycle because the 
phosphorylation reaction (E1Ca2 ---+ E1Ca2P) is blocked. AMP-
PCP is nonhydrolysable, because of the inert stability of 
the P-C-P bond, that has replaced the terminal bridge 
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oxygen of the triphosphate chain of ATP. Thus, AMP-PCP 
off erect the opportunity to study the interaction of an 
ATP-like molecule with various enzymes without the 
possibility of cleavage between the ~,y-phosphates. The 
synthesis of the TNP analogue of AMP-PCP will also 
provide insight into the role of the TNP and adenine 
moieties in the binding of the nucleotide. TNP-AMP-PCP 
was synthesized by the general method involving initial 
preparation of P1-nucleoside-5' P2-diphenyl pyrophoshate 
from AMP and diphenyl chlorophosphate (attacking 
electrophile), followed by displacement of the diphenyl 
phosphate group (leaving group) by a,~-methylene 
diphosphonic acid (the attacking nucleophile) to from 
AMP-PCP (Michelson, 1964) . The TNP-moiety was added to 
the ribose ring of AMP-PCP by reacting with DTNB and TNBS 
( see Scheme 6) . 
1. 9 Ca2 + chel.ators 
Chelating agents or chelators are often used as specific 
metal ion buffers in studies of metal ion-selective 
biological systems to maintain defined free 
concentrations of a specific ion in the micromolar or 
even nanomolar range. 
Three of the chelators used in our studies will be 
discussed, i.e. EDTA, EGTA and BAPTA. EGTA and EDTA are 
regularly used as Ca2+ chelating agents, which have 
apparent calcium equilibrium constants for dissociation 
- 7 - 8 
(K ) at pH 6.8 of 9.73x10 and 9.87x10 , respectively 
app 
(calculated with Fabiato programme) . EGTA is the 
preferred buffer when the system also contains Mg2+, since 
it exhibits a higher Ca2+ /Mg2+ selectivity than EDTA. The 
effectiveness of the Ca2+ chelators depends upon the 
relative rates of (a) Ca2+ transport and (b) Ca2+ uptake 
(or release) by the chelator. At pH 6.8, the predominant 
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EGTA species is The overall complexation 
reaction of Ca2+ with a chelator can be written as: 
k 
Ca2+ + Chelator 4 Ca2+Chelator + nH+ 
k off 
where k on and k off are rate constants. 
Scheme 7 
Structures of EDTA, EGTA and BAPTA 
EGTA 
'' oyo~ 
BAPTA ~ ~ f 




Smith et al., 1977 have found that the values of the on 
6 - 1 - 1 
and off rate constants for EGTA are 1. 5X10 M s and 
about 0.3 
- 1 
s ,respectively at pH 7.0 and 25°C. The 
Ca2+ /Mg2 + discrimination of EGTA presumably stems from a 
binding cavity, which has the right size for Ca
2+ (ionic 
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radius, 0 . 95+), but which cannot constrict further to 
envelop the much smaller Mg2+ (ionic radius, 0.60) because 
the carboxyls at each end of the chain start butting into 
each other (Cotton and Wilkenson, 1972; Tsien, 1980) . The 
nitrogens bind protons with pK of 8.96 and 9 . 58 (Martell 
a 
and Smith, 1974), which makes the Ca2+ buffering level of 
EGTA strongly dependent on pH variations near 7. 0. The 
positively charged protonated nitrogens greatly slow down 
the uptake and release of Ca2+ , as Hellam and Podolsky 
(1969) have found. The apparent forward and backward rate 
constants for the reaction of Ca2 + with EGTA, are 
106 · 3 M-1s-1 and O. 4s-1, respectively. 
Scheme 8 
Structures of DTPA , NTA and HEDTA 
DTPA NTA HEDTA 
At physiological pH, EGTA binds Ca2+ 2 to 3 orders 
magnitude more slowly than ligands without blocking 
protons. It therefore takes EGTA several seconds to 
buffer Ca2 + transiently. BAPTA is one of the newer 
chelators, which also has a large binding cavity, but it 
2+ (10a M-1s-1) binds Ca at a much faster rate than EGTA 
(Tsien, 1980). In BAPTA, benzene rings have replaced the 
methylene groups found in EGTA connecting nitrogen to 
oxygen . The nitrogen pK s are lowered from 8 or 9 to 5 or 
a 
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6. Ca2+ chelation by BAPTA is thus pH insensitive in the 
range 7 to 10 (Tsien, 




It has K values for Ca2+ 
app 
- 2 
l.70xl0 , respectively 
(calculated with Fabiato programme) . The Ca
2
+ /Mg2+ ratios 
4 5 2 
for EGTA, BAPTA and EDTA are 5.3xl0, l.6xl0 and 1.0xlO, 
respectively (Calculated with Fabiato programme). 
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2. EXPERIMENTAL PROCEDURES 
2 .1 Materi a l s : 
The sources of materials were as follows: deionized water was 
used in all the experiments; amylase, Boehringer Mannheim; 
Fluo-3 (pentammonium salt), Molecular Probes, Inc. (Eugene, 
OR); standard atomic absorption Zn2+ solution, SMM Chemicals; 
trichloroacetic acid, Analar; zinc acetate and LaC1 3 , Hopkin 
and Williams. CaC1 2 stock solution solution was prepared from 
Analar CaC03 • CdS04, FeS04 and CuS04, from Analagar. Buffers 
Tris, MOPS, EPPS, MES and NH4C03H, sodium oxalate, AMP, 
tri-n-octylamine, a, P-methylene diphosphonic acid, 
5,5'-dithio-bis(2-nitrobenzoic acid), imidazole, MgC1 2 , ATP, 
chelators NTA, EGTA, EDTA, BAPTA, HEDTA and DTPA, from Sigma; 
2,4,6-trinitrobenzenesulfonic acid and triethylamine, Fluka; 
[45Ca]CaC1 2 , Amersham; glycerol, dimethylformamide, 
acetonitrile, from Merck; diphenyl chlorophosphate, Aldrich; 
tri-n-butylamine, BDH Chemicals; methanol, Burdick and 
Jackson; pyridine, Analgar . TNP-8N3-ATP, -ADP and -AMP were 
used from stock, synthesized originally by the method of 
Seebregts and McIntosh (1989) . HPLC purified TNP-ATP, -ADP 
and -AMP stock was used, synthesized originally by the method 
of Hiratsuka and Uchida, 1977. 
2 . 2 Preparation of skeletal muscle sarcoplasmic 
reticulum vesi cles: 
Sarcoplasmic reticulum vesicles were prepared from the back 
and hind leg muscle of rabbits by the method of Champeil et 
al. (1985). In brief, the muscle was homogenized in a 
blender and the vesicles isolated by differential 
centrifugation. Amylase, 1 µg/ml, was added to the initial 
homogenate in order to decrease glycogen content and 
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phosphorylase contamination to less than 5%, as determined 
by polyacrylamide gel electrophoresis in sodium dodecyl 
sulphate. Protein concentrations were determined from the 
optical absorbance at 280 nm in 50 rnM sodium phosphate, 
pH 7.0, 1%(w/v) sodium dodecyl sulphate, using a conversion 
factor of 1 absorbance unit= 1 mg of protein/ml. The factor 
was based on the Lowry method (Lowry et al., 1951) using 
bovine serum albumin as standard. The vesicles were finally 
resuspended in a medium of 5 rnM imidazole, pH 7.4 and 
0. 3 M sucrose at a concentration of about 35 to 40 mg of 
protein/ml and stored at -70°C. 
2.3 Photolabeling: 
TNP-8N3-nucleotides (5 µM) were irradiated in a medium 
containing 25 rnM NH4HC03/TMAH (pH 8. 5), 1 rnM MgCl2, 
20% (w/v) glycerol, 0.5 rnM EGTA and 1.0 mg of SRV protein/ml 
Ca2+ATPase. Irradiation was performed at room temperature in 
quartz cuvettes with a Xenon light source of 150 Wand with 
a front facing reflector located behind the cuvette. The 
light beam was filtered in front and behind by toluene 
contained in standard ( 1 cm path length) quartz cuvettes. 
The irradiation time was 2 min. Under these conditions and 
in the absence of azido nucleotide, inactivation of ATPase 
activity was less than 3% (Seebregts and McIntosh, 1989). 
Following irradiation, 0.1 rnM ATP was added to the samples 
and then passed through a column (0.3 X 1 cm) of Dowex AG1X4 
resin (HC03- form), equilibrated with 25 rnM NH4HC03, to 
remove noncovalently attached nucleotide. Loss of protein 
was approximately 10% and the fluorescence of the samples 
was compared to controls that has also been passed through 
the columns. The addition of ATP aided removal of 
noncovalently bound TNP-8N3-nucleotides (Seebregts and 
McIntosh, 1989). 
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2 . 4 TNP - nucleot ide superfluorescence: 
ATP-induced superfluorescence was measured with SRV 
(0.2 mg of protein/ml) in a medium containing 
100 rnM EPPS/TMAH (pH 8. 0), 5 rnM MgC1 2 , 20% (w/v) glycerol, 
50 µM CaC1 2 • The TNP-nucleotides were added to the cuvette 
as indicated in the appropriate traces. Phosphorylation of 
Ca2+ATPase was initiated by the addition of 100 µM ATP. 
EGTA ( O. 5 rnM) was added to quench the super fluorescence 
signal. 
Pc induced superfluorescence was measured in the following 
manner: SRV (final concentration, 1.0 mg of protein/ml) was 
added to 25 rnM NH 4HC03 /TMAH (pH 8. 5), 1 rnM MgC1 2 , 
20% (w/v) glycerol, 0.5 rnM EGTA (the irradiation medium, see 
later). The suspension was diluted 5-fold into a medium 
containing 100 rnM MES/TMAH (pH 6 . 4), 6 rnM MgC1 2 , 0.4 rnM EGTA 
and 20% (w/v) glycerol, prior to fluorescence measurements . 
The final pH was 6. 5. Phosphorylation of Ca2+ATPase was 
initiated with 10 rnM Pi (potassium salt, pH 7. 0). CaC1 2 
(total concentration 0.6 rnM) was added to quench the 
superfluorescence signal. Fluorescence measurements were 
performed with a SPEX FluoroMax spectrofluorometer with the 
excitation and emission wavelengths set at 418 and 530 nm, 
respectively. 
2 . 5 Pi -induced superfluorescence i n the reverse direction of 
catalysis : 
2.5 . 1 Tethered TNP-nucleotides : 
The TNP-8N3-nucleotides were tethered to Ca
2+ATPase as 
described previously in the irradiation buffer . 
Noncovalently bound TNP-8N3-nucleotides were removed as 
before . Prior to the fluorescence measurements, the sample 
was diluted 5-fold into a medium containing 100 rnM MES/TMAH 
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(pH 6.4), 6 rnM MgC1 2 , 0.4 rnM EGTA and 20% 
(the fluorescence medium) . The final 
(w/v) glycerol 
pH was 6. 5. 
Phosphorylation of 
addition of 10 
Ca2+ATPase was initiated 
rnM Pi (potassium salt, 
Superfluorescence was quenched by the addition of 
upon the 
pH 7. 0) . 
1. 0 rnM total CaC1 2 (pH 5. 5) or O. 6 rnM total CaC1 2 (pH 6. 0 
and 6.5). The reaction was also monitored at pH 5.5 and 6.0. 
The irradiation mixture was then diluted into the following 
buffer solutions instead: 100 rnM MES/TMAH (pH 5.35) and 
100 rnM MES/TMAH (pH 5.8) containing 6 rnM MgC12 , 0.4 rnM EGTA 
and 20% (w/v) glycerol, respectively. 
2.5.2 Free TNP-nuc1eotides: 
The reaction was also monitored with free TNP-nucleotides. 
The irradiation buffer, containing SRV ( 1. 0 mg of 
protein/ml), was diluted 5-fold into the appropriate buffer 
as before. The free TNP-nucleotide was added to the cuvette 
as indicated in the appropriate traces. 
Phosphorylation of Ca2+ATPase was also initiated in the 
forward direction upon the addition of 1. 0 rnM total CaC1 2 
(pH 5.5), using 5 µM free TNP-8N3-ATP, -ADP, TNP-ATP or -ADP 
as substrate. The irradiation buffer was diluted 5-fold into 
the appropriate buffer as before and the nucleotides were 
added to the cuvette as indicated in the figures. 
The superf luorescence signal ( in the forward direction of 
catalysis) was enhanced by the presence of 10 rnM Pi 
(potassium salt, pH 7.0), but this time the enzyme was pre-
incubated with 1.2 rnM total CaC1 2 (pH 5.5). 
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2.6 Hydrolyis of TNP-nucleotides: 
SR-catalyzed hydrolysis of the TNP-ATP and -ADP and of 
TNP-8N3-ATP, -ADP was performed (in the dark for the latter 
two) at 20 °C in 25 mM MES/TMAH pH 5.5 containing 
0 .1 mM CaCl2 or 10 mM EGTA, 5 mM MgC12, 0 .1 mg/ml Ca2+ATPase 
and 5 µM nucleotide. In some cases thapsigargin ( 3-fold 
molar excess over Ca2+ATPase, i.e. 0. 3 µM) was included in 
the medium. At timed intervals, the reaction was stopped by 
the addition of neat acetonitrile (to 50%), 10 mM EDTA and 
20 mM Tris. The acetonitrile was blown off under a N2 stream 
and the sample chromatographed on a C18 column using a 
System Gold HPLC system (Beckman Instruments) with the dual-
pump Programmable Solvent Module 126 and Scanning Detector 
Module 167. The nucleotides were monitored at 408 nm and 
eluted with a linear gradient of 10 mM KPi / 60% (v /v) 
acetonitrile, 10 mM KPi pH 6.0. Quantitation was by peak 
area. 
2. 7 Ca2 + transport: 
Transport supported by TNP-ATP and -ADP, TNP-8N3-ATP and 
-ADP was performed (in the dark for the latter two) in the 
same media and temperature as for the hydrolysis except that 
45CaC12 was used. Aliquots were filtered on Millipore 0.45 µm 
filters at timed intervals and washed with ice-cold assay 
medium containing 10 mM EGTA, instead of Ca2+. The filters 
were assayed for radioactivity. 
2.8 TNP-AMP-PCP synthesis: 
AMP was phosphorylated to the triphosphate form using the 
anion-exchange procedure of Michelson (1964). 10 µmoles 
AMP.H20 (free acid, Sigma grade) was dissolved in 100 µl 
absolute methanol containing 10 µmoles tri-n-octylamine 
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(3.53 mg). The methanol was removed under a N2 stream. The 
residue was dissolved in 50 µl DMF. The reaction was carried 
out in a 50 µl Hamilton syringe. The solubilized residue was 
taken up first, followed by 3 µl diphenyl chlorophosphate 
(15 µmoles) and 4 µl tri-n-butylamine (20 µmoles). The 
contents were expelled and retaken up quickly and the 
reaction was allowed to continue for 2 h at room 
temperature. If a precipitate formed, it was dissolved by 
taking up a small aliquot of tri-n-butylamine. The product, 
P1-adenosine P2-diphenyl pyrophosphate, was added slowly to 
a solution of methylenediphosphonic acid (20 µmoles, 
3.52 mg), tri-n-butylamine (40 µmoles, 9.4 µl) and 100 µl 
pyridine. After reacting for 3 h at room temperature, the 
sample was freeze-dried. The residue was dissolved in 400 µl 
water and 1.2 ml dry diethyl ether was added. The two phases 
were separated by freezing the water layer at -20 °C. The 
purity of the formed product was monitored by TLC using PEI 
cellulose plates and 1 M LiCl. The AMP-PCP was purified on a 
Whatmann DE52 (HC03- form, 1. 5 cm x 3 cm) anion exchange 
column using an linear gradient up to 250 rnM TEAB buffer. 
The TEAB buffer was freshly prepared by bubbling CO2 through 
a 1 M triethylamine solution until pH 7.4 was reached, and 
the necessary dilution was made. Fractions ( 10 ml) were 
collected and absorbance determined at 259 nm The 
fractions that contained the majority of the AMP-PCP were 
pooled and concentrated. Quantitation of AMP-PCP was by 
absorbance at 259 nm using the extinction coefficient of ATP 
(15.9 au/rnM/cm). Addition of the TNP-group (trinitrophenyl) 
to the ribose ring was accomplished in the following manner: 
10 µmoles AMP-PCP was dissolved in 250 µl water and added to 
250 µl freshly prepared 0.8 M Na2C03 /NaHC03 buffer containing 
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10 mg (34 µmoles) 2, 4, 6-trinitrobenzene sulfonic acid. The 
reaction was continued overnight for 16 h at room 
temperature. The TNP-AMP-PCP was then purified on a column 
(4 cm X 0.5 cm) of Whatman DE52 anion exchange resin 
equilibrated with water. The column was developed with 0.2, 
0. 5 and 1 M ammonium formate. The desired product eluted 
with the highest concentration. Quantitation of TNP-AMP-PCP 
was measured by absorbance at 408 nm using the extinction 
coeffient of TNP-ATP (26.4 au/mM/cm). The yield was 19%. The 
purity of the synthesized TNP-AMP-PCP was checked by C1s 
HPLC. (Solvent A: 10 mM KPi , pH 6.0; Solvent B: 60% (v/v) 
acetonitrile/10 mM KPi , pH 6.0) 
2.9 Fluorescence measurements relating to the chelator 
effect on [Ca2 + J 1.im and Ca2 + transport activity: 
Free [Ca2+] was determined by measuring the fluorescence of 
Fluo-3, using a SPEX FluoroMax spectrofluorometer. The 
emission and excitation wavelengths were 535nm and 509nm 
respectively. 
[Ca2+] free was calculated according to Molecular Probes: 
where 
Kct = Binding constant of Ca2 + to Fluo-3 ( 450 nM) 
F = Fluorescence of the indicator at experimental Ca2 + levels 
Fmin = Fluorescence in the absence of Ca2+ 
Fmax = Fluorescence of the Ca2+ -saturated dye 
SRV, (final concentration: 0.25 mg of protein/ml) were 
diluted in 20 mM Tris/MOPS, pH 6.8, containing 20 nM Fluo-3, 
5 mM MgC1 2 and 5 mM potassium oxalate (standard buffer). The 
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appropriate chelator concentration was added and the 
fluorescence signal measured. The Ca
2+ATPase was activated 
by the addition of ATP ( final concentration 2 rnM) • The F max 
and F min were determined by the addition of 400 µM CaCl2 and 
10 rnM EGTA, respectively. CaC12 (20 µM) aliquots, were added 
to the mixture as indicated in the appropriate figures. 
EGTA effect on Ca2+ activation of transport was measured by 
a Ca2+-infusion method. The experiments were carried out in 
the standard buffer solution containing 2. 5 µM EGTA. The 
enzyme was activated as before by 2 rnM ATP and at time t 1 , 
the infusion of 1 rnM CaC12 at a convenient rate was started, 
using an ABU 80 Autoburette (Radiometer Copenhagen). 
Transport is presumed to be equivalent to the infusion rate. 
The slopes of the plots were extrapolated to time t o and the 
fluorescence intensity was recorded and [Ca
2+] fi= calculated. 
2.10 Determination of [Zn2 +] in SRV preparations: 
SR vesicles were prepared for Zn2+ analysis by the modified 
method of Davies et al., 1968. SRV were diluted 10-fold with 
metal-free water and added to 1 ml of 10% TCA. The mixture 
was left for 10 min, with mixing in between, and centrifuged 
at 30 000 rpm on Beckman Model TJ-6 centrifuge. The 
supernatant was used for the zinc analysis. Standard zinc 
solutions were prepared from an atomic absorption commercial 
zinc solution (10 000 ppm in O .1 N percloric acid): 4, 8, 
16, 20 and 24 µM. The measurements were performed with a 
Varian Atomic Absorption Spectrometer AA-10, using a Zn
2+ 
hollow cathode lamp. A 10% (w/v) TCA solution was used as 
blank. 
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2.11 Influence of [Zn2 +] on the Fluo-3 fluorescence signal: 
SRV (0.25 mg of protein/ml), were incubated in 
20 mM Tris/MOPS, pH 6.8, containing 20 nM Fluo-3, 5 mM MgC1 2 
and 5 mM potassium oxalate. The Ca2+ATPase was activated by 
the addition of 2 mM ATP. Aliquots of a zinc acetate 
solution were added in steps of increasing concentration. 
The increase in fluorescence after each Zn2+ aliquot was 
recorded and plotted against total Zn2+ added. The effect of 
1 µM HEDTA on ZnFluo-3 fluorescence was performed under the 
same reaction conditions. 
2. 12 Effect of Zn2 +, ccf+, Fe2 + and cu2+ on Ca2 + transport 
rate measured with Fluo-3: 
SRV (0.25 mg of protein/ml), were incubated in 
20 mM Tris/MOPS, pH 6.8, containing 20 nM Fluo-3, 5 mM MgC1 2 
and 5 mM potassium oxalate. The Ca2+ATPase was activated as 
before by 2 mM ATP. An aliquot of 20 µM Ca2+ was added 
before and after the addition of 1. O µM HEDTA. 1. O ~lM Zn2+, 
O .1 µM Cd2+, O. 8 µM Fe2+ or O. 8 µM Cu2+ was then added as 
indicated in the appropriate traces. After the addition of 




ATP accelerates most steps of the Ca
3+ATPase transport 
cycle, including E1P -, E2P and Ca
2+ release to the lumen 
(Champeil and Guillain, 1986; Wakabayashi and Shigekawa, 
1986), E2 P hydrolysis, Pi binding (Champeil et al., 1988; 
Mintz et al., 1990) , and the Ca2+ -induced conformational 
change, E2 -, E1Ca2 (Sumida et al., 1978; Takisawa and 
Tonomura, 1978; Scofano et al., 1979; Inesi et al., 1980; 
Guillain et al., 1981; Pickart and Jencks, 1984). To analyze 
the effect of a nucleotide on the enzyme catalytic cycle, 
the use of nonhydrolysable ATP analogues is more convenient 
than ATP, as it avoids perturbing the experimental results 
by the phosphorylation reaction. Previously it has been 
found that TNP-ATP and TNP-ADP are not substrates or 
hydrolyzed by Ca2+ATPase (Watanabe and Inesi, 1982; Dupont 
et al., 1985) and that low concentrations of TNP-ATP and 
TNP-ADP accelerate ATP hydrolysis (Seebregts and McIntosh, 
1989; Dupont et al., 1985) and E2 P hydrolysis (Champeil et 
al., 1988). Lys-492 has been implicated in binding both 
catalytic and regulatory ATP by affinity labeling and site-
directed mutagenesis (Murphy, 1977; Seebregts and McIntosh, 
1989; McIntosh et al., 1992; Yamagata et al., 1993; 
Stefanova et al., 1993; McIntosh and Woolley, 1994; Yamasaki 
et al., 1994; McIntosh et al., 1996) . Covalent tethering 
TNP-8N3-ATP to Lys-492 by light activation partially 
uncouples the pump (McIntosh and Woolley, 1994), but still 
permits the large fluorescence enhancement of the nucleotide 
on formation of E2 P (Seebregts and McIntosh, 1989; and see 
below). There was an indication from prior results 
(Seebregts and McIntosh, 1989) that the quenching of 
tethered TNP-8N3-AMP 
compared with the 
nucleotide. 
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superfluorescence by Ca2+ is retarded 
situation of the untethered TNP-
The following series of experiments were designed to explore 
the role of free and tethered TNP-nucleotide regulation of 
steps E2P ~ E2 ~ E1Ca2 and the involvement of Lys-492, 
through studying the rate of superfluoresence quenching by 
Ca2+. First, the experimental system and superfluorescence 
are explained. 
3.1.1. The phenomenon of TNP-nucleotide superfluorescence: 
3.1.1.1 ATP-induced superfluorescence: 
The Ca2+ATPase is phosphorylated by ATP in the presence of 
Ca2+ in the forward direction of catalysis. ATP-induced 
superfluorescence was initiated at pH 8.6 in the presence of 
TNP-8Nr AMP, SRV, Mg2+ and Ca2+ as indicated in Fig 10. Note 
that ATP-induced superfluorescence is greater at alkaline 
pH. Adding TNP-8N3-AMP to SRV produced in increase of 
fluorescence intensity, due to its binding to Ca2+ATPase. 
ATP addition led to a pronounce increase in fluorescence, 
the so-called superfluorescence. The reason for this is the 
binding of TNP-8N3-AMP to the phosphoenzyme (E2P) formed 
during enzyme turnover (Watanabe and Inesi, 1982; Nakamoto 
and Inesi, 1982; Bishop et al, 1984, 1987; Davidson and 
Berman, 1987). The superfluorescence was quenched by EGTA 
addition, which chelated Ca2+ and inhibited subsequent 
enzyme turnover and E2P formation. The rate constant for the 
decay in superfluorescence is possibly a combination of the 
rate constants of phosphoenzyme hydrolysis (E2P ~ E2) and 
the conformational change (E2~ E1). 
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3.1.1.2 Pi-induced superfluorescence: 
Phosphorylation of Ca2+ATPase with Pi requires that the 
enzyme is in a Ca2+-free form (de Meis and Vianna, 1979). 
This is accomplished by chelation of Ca2+ with excess EGTA. 
Binding of TNP-8N3-AMP to Ca2+ATPase increased the 
fluorescence (Fig 10). Pcinduced superfluorescence in 
contrast to ATP-induced superfluorescence is maximal low pH. 
The latter ensures that the enzyme is predominantly in the 
E2 species, which is reactive to Pi . Addition of Pi yields a 
superfluorescence signal, becaus~ of the binding of 
TNP-8N3-AMP to the same E2P species as generated in the 
forward direction of catalysis, as seen above. The 
superfluorescence was quenched by Ca2+, due to phosphoenzyme 
hydrolysis and the formation of a low 
fluorescence E1Ca2. TNP-8N3-AMP complex. The decay rate of 
superfluorescence is dependent on the rate constants of 
three steps E2P ~ E2 and E2 ~ E1 ~ E1Ca2. 
3. 1. 2. Rate of Ca2 + inhibition of Pi -induced 
superfluorescence: 
3.1.2.1 Free vs. tethered TNP-8N3-AMP: 
As mentioned before, results from Seebregts and McIntosh 
(1989) indicated that quenching of tethered TNP-8N3-AMP 
superfluorescence by Ca2+, is retarded compared to the 
situation of free TNP-8N3-AMP. This was verified in Fig 11. 
The Pcinduced superfluorescence and quench by Ca2+ shown 
above for TNP-8N3-AMP is compared with results obtained with 
the tethered nucleotide (Panels A and B) . In the case of 
free TNP-8N3-AMP, 90% of the decay of fluorescence was 
described by a single rate constant k = 0. 25 s-1. Addition 
of Pi to tethered TNP-8N3-AMP SRV produced an increase in 
fluorescence, although smaller than in the case of free 
TNP-8N3-AMP, compatible with partial derivatization of 
































































































































- ~ ·-,,, C 
















































































































































































































































































































































































































































































































































































































































































































Lys-492. Addition of Ca2+ again led to superfluorescence 
decay, but the quench kinetics was more complex. The decay 
in fluorescence was biphasic ( ktast = 0. 02 s -1 and 
ksiow = 0. 0035 s-1) . Unfortunately there was a high background 
drift in fluorescence with tethered nucleotides and this is 
possibly the cause of the slow phase. If the fast phase is 
taken as representing the true decrease in 
superfluorescence, it can be concluded that the rate 
constant for this decrease is at least 10-fold slower 
compared with the situation with the free nucleotide. 
3.1.2.2 Comparison between tethered TNP-8N3 -ATP, -ADP and 
-AMP: 
Ca2+ quenching of superfluorescence involves at least three 
steps, two of which are probably associated with significant 
reverse reactions, 
the literature 
E2P ~ E2 ~ E1 ~ E1Ca2. It is known from 
that ATP accelerates: phosphoenzyme 
hydrolysis (E2P ~ E2) (Champeil et al., 1988; Mintz et al., 
1990), and the Ca2+-induced conformational change, E2 ~ E1Ca2 
(Sumida et al., 1978; Takisawa and Tonomura, 1978; Scofano 
et al., 1979; Inesi et al., 1980; Guillain et al., 1981; 
Champeil et al., 1983; Pickart and Jencks, 1984; Fernandez-
Belda et al., 1984; Wakabayashi et al., 1990). We therefore 
investigated whether the Ca2+ quenching of tethered 
TNP-8N3-ATP and/or -ADP may be faster than that with 
TNP-8N3-AMP. A comparison of Ca2+ quenches with TNP-8N3-AMP, 
-ADP and -ATP is shown in Fig 12 and the rate constants 
listed in Table 1. The software package SigmaPlot 2.01 was 
used to determine the rate constants by regression analysis. 

















































































































































































































































































































































































































































































































































































































































































































































Rate constants of tethered TNP-nucleotides superfluorescence 
quench ra tesa 
Nucleotide pH Rate constant (S -) 
TNP-8N3-AMP 5.5 0.018 
6.0 0 .020 
6.5 0.020 
TNP-8N3-ADP 6.5 0.025 
TNP-8N3-ATP 6.5 0.023 
a: 60 to 80 % of of the superfluorescence quench was described by a 
single rate constant. 
As mentioned earlier, there was a high background drift in 
fluorescence with tethered nucleotides and this is possibly 
the cause of the slow phase (ksiow = 0.0025 to 0.0035 s-1 ). 
This slow phase always represented less than half of the 
signal. The quench was performed at pH 5.5, 6.0 and 6.5 for 
all three nucleotides. No acceleration of the 
superfluorescence quench rate constant of the faster phase 
was oberved for the tethered TNP-8N3-ATP and -ADP compared 
to TNP-8N3-AMP, as can be seen from Table 1. The decay 
profiles for TNP-8N3-ATP and -ADP were superimposable 
(Fig 12) and the rate constants are only given for pH 5.5. 
Increasing the pH also had no effect on the quench rate 
constant. 
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3.1.2.3 Complicated kinetics with free TNP-nucleotides: 
3. 1. 2. 3. 1 TNP-8N3 -ATP, -ADP and -AMP: 
The pH dependence (5.5, 6.0, 6.5) of the Ca2+-induced quench 
kinetics with TNP-8N3-ATP, -ADP and -AMP is shown in Fig 4. 
In these experiments, Pcinduced superfluorescence was 
initiated in 0.5 rnM EGTA and inhibited by the addition of 
1.0 rnM (pH 5.5) or 0.6 rnM total CaC1 2 (pH 6.0 and 6.5) 
(Fig 13). The overall level of superfluorescence was greater 
at lower pH. The quench kinetics with TNP-8N3-.AMP was 
monophasic 80-90% of the time course at each pH and 
increased with increasing pH (k = 0.023, 0.090 and 0.25 s-1 
at pH 5.5, 6.0 and 6.5 respectively). The kinetics was more 
complicated with the other two nucleotides. In the case of 
TNP-8N3-ADP at pH 5.5, there was an initial rapid quench of 
superfluorescence and then it increased transiently and 
finally ceased after 500 s. With TNP-8N3-ATP the initial 
drop was barely visible and the final cessation delayed to 
600 s. At higher pH the extended plateau of 
superfluorescence was shorter, and hardly detectable at 
pH 6. 5. One explanation for the complex kinetics observed 
could be enzyme turnover. It is possible that Ca2+ plus a 
substrate could promote phosphorylation in the forward 
direction of turnover, yielding E2 P and hence 
superfluorescence. This could perhaps be expected for 
TNP-8N3-ATP, because it has been shown previously that the 
nucleotide is a substrate and supports Ca2+ transport 
(McIntosh and Woolley, 1994). It was however unexpected for 
TNP-8N3-ADP to display such a phenomenon, because neither 
ADP nor any ADP analogue has yet been identified as a 
substrate of Ca2+ATPase in the forward direction of 
catalysis. Other possibilities that we considered were time-
dependent reversible aggregation at low pH, ATP 





































































































































































































































































































































































































































































































































































































































































































































































































































































ATP or TNP-8N3-ADP 
51 
converting the TNP-nucleotides into 
into TNP-8N3-ATP. An aggregation 
phenomenon was ruled out by the absence of similar changes 
in the baseline fluorescence. The other possibilities will 
be addressed at a later stage. 
3.1.2.3.2 TNP-ATP, -ADP and -AMP: 
Whilst TNP-8N3-ATP has been shown to be a substrate of the 
pump, the nonazido parent TNP-nucleotides are apparently not 
(Watanabe and Inesi, 1982; Dupont et al., 1985) . Therefore 
the same experiments were performed with the nonazido 
TNP-nucleotides and the results are shown in Fig 14. Again 
the overall superfluorescence diminished with increasing pH, 
and the kinetics for TNP-AMP was monphasic. The quench 
kinetics for TNP-ADP and TNP-ATP were again complex and very 
similar to the azido compounds except that the secondary 
plateau of superfluorescence was shorter. 
3.1.2.4 Extremely fast inhibition of Pi-induced 
superfluorescence by EDTA: 
As mentioned previously, Ca2+ quenching of superfluorescence 
involves at least three steps, two of which are probably 
associated with significant reverse reactions, 
E2P ~ E2 ~ E1 ~ E1Ca2 • In order to acertain whether the 
kinetics we were observing was related to phosphoenzyme 
hydrolysis or a subsequent step, EDTA was used to quench the 
reaction. The results obtained with the TNP-8N3-nucleotides, 
the nonazido TNP-nucleotides, and with the tethered azido 
nucleotides are shown in Fig 15. In all cases EDTA quenched 
the superfluoresence faster than could be monitored 
manually. 
































































































































































































































































































































































































































































































































































































































































































































































































It is concluded that the kinetics observed with the Ca
2
+ 
quench, monitors a reaction subsequent to dephosphorylation. 
Most likely this is the E2 -; E1 conformational change. 
3.1.3. Hydrolysis of TNP-nucleotides by SRV: 
3. 1. 3. 1 TNP-8N3 -ATP and -ADP: 
The possible hydrolysis of TNP-nucleotides by Ca2+ ATPase was 
tested directly by measuring the individual TNP-species by 
HPLC. Representitive HPLC profiles of the time dependence of 
hydrolysis of TNP-ATP, pH 5.5, are shown in Fig 16. At O min 
-95% of the nucleotide is present as the triphosphate 
species. With increasing time this species was converted 
into the di- and monophosphate nucleotide. Quantitation of 
the reaction by peak area provided the results shown in 
Fig 17. In the case of TNP-8N3-ATP (top frames) and in the 
presence of Ca2+ (first frame) there is a time dependent 
hydrolysis of the triphosphate, with the concommitant 
formation of first TNP-8N3-ADP, reaching a steady state 
level after 2 min, and then TNP-8N3-AMP gradually increases 
in concentration. In the absence of Ca2+ (second frame) 
hydrolysis is only evident after 6 min. There is no 
formation of TNP-8NrAMP during the- entire time course. In 
the presence of thapsigargin (a specific inhibitor of Ca2 + 
ATPase), hydrolysis of TNP-8N3-ATP is very slow and again 
there is no hydrolysis of the diphosphate to monophosphate 
nucleotide. The Ca2 + -dependent component of hydrolysis is 
obtained by subtracting the activity in the presence of EGTA 
from the total activity and the result is shown in the last 
frame. There is a burst of TNP-8N3-ADP formation, followed 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.1.3.2 TNP-ATP and -ADP: 
In the case of TNP-ATP, hydrolysis in the presence of Ca
2+ 
is slower and the slower promotion of TNP-ADP and 
subsequently TNP-AMP is evident. The situation is not very 
different in the absence of Ca2+ (second frame) except that 
there is virtually no hydrolysis of TNP-ADP. Similar results 
were obtained in the presence of thapsigargin. The high 
hydrolysis rates of TNP-ATP in the absence of Ca
2+ preclude 
measurements of a Ca2+ -dependent component. However, there 
was a clear Ca2+-dependent and thapsigargin-inhibitable 
conversion of TNP-ADP into TNP-AMP. 
The results suggest that TNP-8N3-ATP and -ADP as well as 
TNP-ADP are substrates of Ca2+ATPase. TNP-ATP may be as well 
but such activity is masked by a high non Ca
2+ATPase 
activity. It should be borne in mind that the conditions 
used in the above experiments were somewhat different from 
those performed in Fig 13 and 14 (i.e. glycerol was absent) 
and the protein concentration was less). 
Similar experiments using TNP-8N3-ADP and TNP-ADP are shown 
in Fig 18. In these cases hydrolysis from the diphospho to 
monophospho species were the same and almost entirely 
Ca2+-dependent. The rates of hydrolysis for each nucleotide 
is listed in Table 2. 
3. 1. 4. 45Ca2 + transport studies: 
The ability of the TNP-nucleotides to support Ca
2+ transport 
under the same conditions as used for the hydrolysis 
experiments is shown in Fig 19. TNP-ATP and -ADP supported 
low rates of Ca2+ transport. The low rate coupled with 


































































































































































































































































































































































































































































































































































































































rates at different nucleotide concentration. The initial 
rate of transport by the two nucleotieds is similar 
(i.e. 2-2.3 nmoles/15 s/mg of protein or 
8-10 nmoles/min/mg of protein) . The lack of any lag in 
activation of transport suggests that TNP-ATP is in fact a 
substrate of Ca2+ATPase. Transport was more rapid with the 
azido nucleotides (up to 32 and 25 nmoles/min/mg of protein 
for TNP-8N3-ATP and -ADP respectively) and an approximate Km 
of 0.5 µM for both nucleotides. 
Table 2 
Rates of TNP-nucleotide hydrolysis and Ca2+ 
transport (nmoles/min/mg of protein) 
TNP-nucleotide Ca2+ transport Hydrolysis Coupling 
TNP-8N3-ATP 32 15 2.1 
TNP-8N3-ADP 25 10 - 12 2.5 -
ratio 
2.1 
TNP-ATP 8 - 10 Unmeasurable Unmeasurable 
TNP-ADP 8 - 10 5 1. 6 - 2.0 
3.1.5. TNP-superfluorescence in the forward direction of 
catalysis: 
The demonstration that at least three of the free 









superfluorescence could be followed in the forward direction 















































































































































































































































































































































































































































































































































Fig 2 O. Addition of Ca2+ , produced a very small inunediate 
change in fluorescence which was followed by a slow decline 
over approximately 300 s. This time span is compatible with 
hydrolysis of the nucleotide. A larger initial rise was 
found with TNP-ADP, and the subsequent slower phase of 
quenching was more evident and faster compared with the 
triphospate nucleotide. 
In the case of the azido nucleotides the initial rise in 
superf luorescence on the addition of Ca
2
+ was more 
significant, but the slower quench less obvious. 
If the slower phases are associated with hydrolysis of the 
nucleotides, it seems that the nonazido species are 
hydrolysed faster that the azido ones. This is contrary to 
what was found in Fig 13 and Fig 14. The difference could be 
due to the presence of glycerol in the fluorescence medium. 
There still appears to be a discrepancy between the low 
levels of fluorescence obtained in the above experiments in 
the forward direction of catalysis compared with the high 
levels found in Pi -induced fluorescence following quenching 
with Ca2+ (Fig 15 and 16). 
3.1.6. Pi enhances TNP-nucleotide fluorescence in the 
forward direction of catalysis: 
Accordingly, the above experiments were repeated in the 
presence of 10 rnM Pi (Fig 21). It can be seen that there is 
a very much larger transient increase in superfluoresence, 
particularly in the case of the nonazido species. This 
transient increase appears to be dependent on enzyme 
turnover since the monophosphate species did not exhibit the 
same phenomenon. Notice the difference in scale on the time 
axis between the nonazido and azido nucleotides. It is clear 
that the nonazido species are better substrates than the 


















































































































































































































































































































































































































azido ones. It is also apparent that the length of time 
taken to hydrolyse the triphospho nucleotide is 
approximately double that of the diphospho species 
suggesting, as found above, that the two species are 
hydrolysed at similar r~tes and that the triphospho form is 
hydrolysed twice to yield the monophosphate. Note also that 
there is no time lag in the rise in the superfluorescence 
associated with TNP-ATP hydrolysis suggesting that the 
latter is directly a substrate for the Ca
2+ATPase and does 
not need to be converted into the diphospho form by 
contaminating enzymes. 






the original problem as 
accelerate the quench 
whether TNP-
of Pcinduced 
fl b Ca2+, 1· t super uorescence y 
results that TNP-ATP and -ADP 
cannot be used. 
is clear from the above 
and the azido derivatives 
We therefore synthesized the nonhydrolysable analogue 
TNP-AMP-PCP (see flow diagram, Fig 22). AMP-PCP was purified 
on a DE 52 HC03- anion exchange column with a 0-250 rnM TEAB 
gradient. The product was present in fractions 10 to 16. The 
reaction solvent and excess diphenyl chlorophosphate eluted 
in fractions Oto 2 and unreacted AMP in fractions 4 to 8 
(Fig 23). TNP-AMP-PCP was formed by the reaction of purified 
AMP-PCP with DTNB and TNBS. The product was purified on a 
DE52 anion exchange column and developed with 0.2, 0.5 and 
1 M ammonium formate. Fractions 8 to 13 contained the 
product (Fig 23). A 19% yield from AMP was obtained. The 
purity of TNP-AMP-PCP was monitored by TLC (Fig 24) and HPLC 





























































































































































































































































































































































































































































Flow diagram for the synthesis of TNP-AMP-PCP 
Free acid AMP conversion to tri-n-octylammonium 
salt form 
Reaction of tri-n-octylammonium AMP with 
diphenyl chlorophosphate to yield 
P1-adenosine P2-diphenylpyrophoshpate 
Conversion of P1-adenosine P2-diphenylpyrophoshpate 
to AMP-PCP by the reaction of a,p-methylene 
diphosphonic acid 
Purification of AMP-PCP on a DE 52 HC03-anion 
exchange column with O - 250 mM TEAB gradient 
TNP-AMP-PCP formation by reacting AMP-PCP 
with DTNB and TNBS 
Purification of TNP-AMP-PCP on a DE 52 anion exchange 
column developed with 0.2, 0.5 and 1 M ammonium formate 
Purity check of TNP-AMP-PCP on HPLC and 
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similar Rt value and retention time as TNP-ATP TNP-AMP-PCP 
showed the same absorbance profile as the TNP-nucleotides, 
with absorbance maxima at A2s9 , A4oe and A.470 ( Fig 2 6) . 
TNP-AMP-PCP displayed a similar Pi -induced superfluorescence 
signal as TNP-AMP (Fig 27). 
Figure 24 
Purity check of TNP-AMP-PCP by TLC 
TNP-AMP-PCP, TNP-ATP, -ADP and -AMP were spotted 




TNP-ATP TNP-ADP TNP-AMP TNP-AMP-PCP 
The earlier experiments involving Ca2+ quenching of TNP-AMP 
and TNP-8N3-AMP were repeated and compared with results 
obtained with TNP-AMP-PCP (Figure 28 and Table 3). As can be 
seen TNP-AMP-PCP did not accelerated the quench of 
superfluoresence by Ca2 + , in the pH range 5.5 6.5, 

















































































































































































































































































































Panel A, Comparison between TNP-AMP-PCP, TNP-ATP, -ADP and -AMP. The 
nucleotides were diluted in 10 mM KPi (pH 7.0) with 10 mM KP1 (pH 7.0) 
used as blank. 





















2.0 0.6 mM total ca2• .. -· .. ..... t 













I l ·: 
I · .. 
I .... 
0.5 
l . ······ · ····· .""'\ ~....,,,...,,.....,.. ______ -1·r-----J ~ 10 mM Pi ----
t\ 
5 uM nucleotide 
0--'--.------r-----,------,-----.-----~ 
0 50 100 150 200 250 
Time (s) 
TNP-AMP-PCP fluorescence characteristics compared to TNP-AMP and 
TNP-8N3-AMP 
See legend of Fig 13 for details. The solid, dashed and dotted lines 














































































































































































































































































































the superf luorescence quench can be described by a single 
rate constant (listed in Table 3). 
Table 3 
Comparison between free TNP-8N3 -AMP, TNP-AMP and 
TNP-AMP-PCP superfluorescence quench rates 
Nucleotide pH Rate constant 
TNP-8N3-AMP 5.5 0.023a 
6.0 0.09 
6.5 0.25 
TNP-AMP 5.5 0.023 
6.0 0.09 
6.5 0.28 
TNP-AMP-PCP 5.5 0.03 
6.0 0.05 
6.5 0.12 
a: A fast and slow component of 47 % (ktast = 0.09 s-1 ) and 53 % 
(s- ... ) 
( kstow = 0. 023 s-1 ), respectively, were found for free TNP-8N3-AMP at 
pH 5.5. 
The presence of a small slow phase (0.008 to 0.025 s-1 ) was 
attributed to background drift. Over the pH range 5.5, 6.0 
and 6.5 there was a general increase in the 
superfluorescence quench rate (0.023-0.03, 0.05-0.09 to 
0.12-0.25 - 1 s ' respectively) 
can be concluded that, 
for all three nucleotides. 
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0 200 400 600 800 1000 
Time (s) 
Hydrolysis of ATP compared to the hydrolysis of TNP-nucleotides 
The irradiation buffer was diluted as previously described into the 
fluorescence buffer (see legend of Fig 13). SRV (0.2 mg of protein/ml) 
were incubated in the medium at 20 °C for a minute and then 5 µM TNP-AMP 
or TNP-AMP-PCP, 5 µM ATP and 10 mM Pi were added as indicated. The solid 
and dashed lines refer to TNP-AMP and TNP-AMP-PCP, respectively. 
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triphospho nucleotide does not accelerate the step 
associated with the Ca2+ quench. 
3. 1. 8. Hydrolysis of ATP is comparable to the hydrolysis of 
TNP-nucleotides under these reaction conditions: 
The preceding experiments are somewhat unusual in that 
glycerol is present in the medium. It was therefore of 
interest to compare the results obtained with the TNP-
nucleotides to that obtained with ATP under the same 
conditions. 
Such an experiment, using TNP-AMP or TNP-AMP-PCP as 
fluorescent probes, is shown in Fig 29. It can be seen that 
it takes approximately 200 s to hydrolyse 5 µM ATP, i.e. 
about the same time as it takes to hydrolyse 5 µM TNP-ADP 
( Fig 21) . It can be concluded that, under the conditions 
used, Ca2+-ATPase utilizes ATP and TNP-nucleotides with 
approximately equal facility. 
3. 2 Ca2 + chela tors 
Skeletal muscle sarcoplasmic reticulum Ca2+ATPase binds 
cytoplasmic Ca2+ with high affinity (Kct = 1 µM) and positive 
cooperativity (n8 = 2). In the relaxed state of the muscle, 
the free Ca2+ concentration in the cytoplasm is in the order 
of 0.1 µM (the limiting Ca2+ concentration, 
whereas the luminal free Ca2+ concentration is in the 
millimolar range (Hasselbach and Makinose, 1961; Ebashi and 
Lipmann, 1962). 
The Ca2+ chelator EGTA is routinely used to lower and 
maintain low, free Ca2+ concentrations in solutions to study 
61 
various reactions in the Ca2+ATPase enzyme cycle. An example 
is the phosphorylation of the enzyme in the reverse 
direction of catalysis by Pi , where no Ca
2+ must be bound to 
the enzyme to ensure that the majority of the enzyme will be 
present as the reactive E2 species. Ususally it is assumed 
that the chelator and/or Ca2+chelator complexes do not alter 
the kinetic or binding characteristics of Ca
2+ATPase . 
However, so-called EGTA effect has been reported in various 
systems . 
Ca2+ transport by islet cell plasmamembrane Ca
2+Mg2+ATPase is 
activated by millimolar EGTA, but not stimulated further by 
calmodulin addition (Kotagel et al . , 1983). On the other 
hand, calmodulin stimulation is inhibited by the presence of 
millimolar EGTA suggesting that the ability of CaEGTA to 
activate the Ca2+Mg2+ATPase and increase Ca
2+ transport is 
possibly mimicking the effect of a physiological activator . 
Schatzmann (1973), Al-Jobore and Roufogalis (1983) and 
Weiner and Lee (1972) reported that EGTA increases the 
apparent affinity of the red blood cell Ca
2+ATPase for Ca2 +, 
without enhancing its maximum velocity. Al-Jobore and 
Roufogalis (1981) found that a low Ca
2+ affinity site is 
converted to a high affinity site in the presence of EGTA, 
and that CaEGTA appears to be associated with this 
interconversion. Orlov et al. (1983) provided further 
evidence that EGTA increases the Ca
2+ affinity of Ca2 +ATPase. 
They proposed two models for the EGTA effect: 
1) Ca2+Mg2+ATPase might contain two types of Ca
2+ binding 
sites, with low and high affinity for Ca
2+. The latter is 
manifest in the presence of EGTA. 2) EGTA or CaEGTA enhance 
the Ca2+ affinity for the enzyme either through direct 
interaction with the enzyme or by modifying its 
microenvironment in the membrane. Rossi and Rega (1989) 
62 
investigated the effect of EGTA on the red blood cell 
Ca2+ATPase affinity for ATP. They found that EGTA does not 
increase the apparent affinity for ATP, which means that 
EGTA has its effect at or near the transport sites, 
unrelated to the activation by ATP. It was reported by Frey 
et al. (1981) that EDTA, CDTA and EGTA stimulate GTP 
pyrophosphatelyase, by increasing its affinity for MgGTP 
(the substrate). Segel et al. (1981) investigated the effect 
of EGTA on the lymphocyte plasma membrane Na+K+ATPase. Ca
2+ 
is an inhibitor of the enzyme in the 50-100 µM concentration 
range, therefore EGTA must be present in the assay medium to 
chelate contaminating Ca2+. However, they concluded that the 
enhancement of the enzyme activity is explained by Zn
2+ 
chelation, and not of Ca2+. Kronman and Bratcher (1982) 
provided evidence that CaEGTA binds directly to bovine a.-
lactalbumin. This binding causes a conformational change in 
the protein, resulting in a larger apparent association 
constant for Ca2+. EGTA, EDTA and CDTA all increase initial 
rates of Ca2+ transport by cardiac sarcolemma Na+Ca
2+ATPase 
(Trosper and Philipson, 1984). They suggested that the 
Ca2+chelator complex causes the stimulation. CaEGTA also 
appears to activate the SR muscle Ca
2+ATPase (Berman, 1982). 
The effect is specific for EGTA as EDTA did not provide a 
similar stimulation. 
3.2.1. Ca2 + transport characteristics measured by Fluo-3 
fluorescence: 
Extravesicular free [Ca2+] was measured at 25 °C, pH 6. 8 
with the Ca2+ indicator Fluo-3. The Ca
2+ATPase was activated 
by adding 2 mM ATP, which resulted in a decrease of 
fluorescence to a baseline value (Fig 30). The decrease in 
fluorescence was due to Ca2+ ( in the medium) being 
transported from the medium into the SRV. Upon addition of 
Figure 30 
4.0 
NCCl~00-12 HCC11l(OO-J2 00~~'¢ 10 mM EGTA ';:::, I t!. - Q F max tn 
~ Cl Cl Cllt 
C: 3.0 
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tn 
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0 1.0 :::J -LL 
l\ 'C '/' 'f Fmin 
Baseline fluorescence 400 uM Ca2+ 
0 
0 20 40 60 80 100 120 140 160 180 
Time (s) 
SRV Ca2+ transport characteristics measured by Fluo-3 fluorescence 
Free Ca2+ was determined by measuring the fluorescence of Fluo-3, using 
a SPEX FluoroMax spectrofluorometer. The emission and excitation 
wavelenghts were 535 run and 509 run, respectively. SRV (0.25 mg of 
protein/ml) were incubated at 25 °C in 20 mM MOPS/TRIS, pH 6.8, 
20 nM Fluo-3, 5 mM MgC1 2 and 5 mM potassium oxalate. The Ca
2+ATPase was 
activated by the addition of 2 mM ATP. CaC12 (20 µM) aliquots were added 
to the mixture as indicated in the plot. Fmax and Fmin were obtained by 
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400 uM Ca2+ 
0 I I I I I I I 
0 10 20 30 40 50 60 
Time (s) 
Influence of 7.5 µM EGTA on Fmax and Fmin 
Fmax and Fmin were obtained by the addition of 400 uM CaC1 2 and 
10 mM EGTA, respectively for both the control experiments and in the 
presence of 7.5 µM EGTA. See legends of Fig 29 and Fig 30 for details. 
The solid and dotted lines refer to the control experiment and in the 
presence of EGTA, respectively. 
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20 µM Ca2+ aliquots, the fluorescence increased immediately 
due to the formation of the highly fluorescent CaFluo-3 
complex and decreased again to the baseline value over a 
time frame of 20 s, due to Ca2+ transport into SRV lumen. A 
saturated fluorescence level was achieved upon addition of 
400 rnM Ca2+, the Fmax value. The minimum fluorescence (Fmin l 
level was obtained with the addition of excess EGTA (10 rnM). 
When the baseline fluorescence value was converted to 
[Ca2+] free, it was found to be in the range of 100-200 nM. 
The [Ca2+] free always decreased to a value in this range, 
the so-called [Ca2+] 11m value. 
3. 2. 2. The effect of micromolar EGTA on [Ca2+] 1i•: 
The presence of 7. 5 µM EGTA in the medium resulted in a 
lower fluorescence baseline value on addition of ATP, in 
other words, a lower [Ca2 +] 11m value (Fig 31). Adding an 
aliquot of 20 µM Ca2+, resulted in an immediate fluorescence 
increase. The time for the fluorescence signal to reach the 
baseline value, was slowed from 20 s to 70 s. Thus Ca
2+ 
uptake was retarded in the presence of EGTA. No change in 
Fmax or Fmin was observed ( Fig 32) . 
3. 2. 3. Effect of various chela tors on [Ca
2 +] 1i•: 
It was of interest to investigate 





lowering [Ca2 +] 11ml . The above mentioned experiments were 
performed with EDTA, BAPTA, NTA, DTPA, HEDTA and EGTA at 
various concentrations (1-50 µM) (Fig 33). The average 
baseline fluorescence value after the addition of ATP and 
20 µM Ca2+ aliquots was calculated for each chelator and 
from that , the [Ca2+] lim • The K0 . 5 values for each chelator 




















The effect of various chelators on [Ca2+]lia 
15 20 
The previous experiments were repeated for each chelator at a specific 
concentration. The average baseline fluorescence value was calculated 
and from that, the [Ca2+] lim with the transformation equation. The 
obtained [Ca2+] lim values were plotted against the chelator 
concentrations. The solid circles, squares and triangles refer to EGTA, 
EDTA and BAPTA, respectively, whilst the open circles, squares and 
t riangles refer to DTPA, NTA and HEDTA, respectiyely. 
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Calibration curve for determining Zn2+ lev.ela iri SRV preparations , 
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50% change. These values, or potency of the chelator to 
lower [Ca2+] um, and were found to be similar for each 
chelator, namely O. 5 µM. One explanation for the chelator 
effect might be the presence of heavy metal ions, such as 
Zn2+, Al 3+, Cu2+ or Cd2+. 
3. 2. 4. Activation of the pump by micromol.ar EGTA at 1.ow Ca2 + 
concentrations: 
Previously Berman (1982) found that CaEGTA appears to 
activate the pump at low free Ca2+ concentrations, by 
measuring Ca2+ transport with a Ca2+-electrode and Ca2+ -stat 
method. This effect was also produced with the Fluo-3 
system, using a Ca2+ -infusion method ( Fig 34) . At low free 
Ca2+ concentrations (lower than 100 nM), the binding 
affinity of Ca2+ to Ca2+ATPase was increased in the presence 
of 2.5 µM EGTA. 
3.2.5. Determination of Zn2 + 1.evel.s in SRV preparations 
Zn2+ content of SRV preparation was determined by atomic 
absorption spectrometry. A calibration curve was obtained 
using standard zinc solutions (Fig 35). 
Table 5 lists four SRV preparations and the Zn2+ levels. On 
average a SRV preparation contained 18 µM Zn2+ or 
O. 52 nmole/mg of protein. The concentration of SR protein 
used in the fluorescence experiments was 0.25 mg of 
protein/ml, thus on average a minimum of about O .13 µM Zn2+ 
was present in the assay medium. 












































































































































































































































































































































































































































































































































Calculating [Zn2+] in SRV preparations with atomic 
absorption spectrometry 
SRV preparation [SRV] (mg/ml) [Zn2 +] (µM) [Zn
2 +] 
1 37.3 25 
2 37.7 17 
3 33.2 16 






3.2.6. Influence of Zn2 + on the Fluo-3 fluorescence signal 
To investigate the contribution of ZnFluo-3 fluorescence to 
the overall fluorescence signal, aliquots of Zn2+ were added 
to the standard assay mixture. Addition of Zn2+ caused an 
increase in the fluorescence signal, in much the same way as 
Ca2+ does (Fig 36). A plot of fluorescence versus total 
[Zn2+] indicates that 0.13 µM Zn2+ would bring about a 0.018 
arb. unit fluorescence increase. Thus complexing Zn2+ by the 
chelators could significantly lower the apparent [Ca2+] lim • 
3.2.7. Effect of 1 µM HEDTA on ZnFluo-3 fluorescence signal: 
To test this possibility further, SRV ( 0. 25 mg of 
protein/ml) were incubated in the standard assay medium. 
After activation with 2 mM ATP, 1 µM HEDTA was added. This 
led to the predicted drop in fluorescence, i.e. a lower 
fluorescence baseline value and [Ca2+] lim ( Fig 37A) . Addition 
of 0.1 and 0.2 µM Zn2+ aliquots led to a transient increase 
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Effect of 1 uM HEDTA on Zn2+Fluo-3 fluorescence 
SRV were incubated in the same buffer solution and Ca2+ATPase activated 
with 2 mM ATP, as mentioned in the legend of Fig 26. HEDTA (1 µMl and 
increasing concentration of 250 µM zinc acetate was added as before. 
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concentrations raised the baseline fluorescence and resulted 
in a higher final, steady state fluorescence. Further 
additions caused only increases in fluorescence. This 
possibly indicates that HEDTA was saturated with Zn2+ . The 
fluorescence level reached saturation with 0.8 µM total 
Zn2+ . The rise and subsequent decrease in fluorescence on 
addition of small amounts of Zn2+ might possibly be 
explained by Zn2 + binding rapidly to Fluo-3 followed by the 
slow chelation of Zn2+ by HEDTA. The drop in fluorescence 
after the addition of 1 µM HEDTA, is equivalent to the 
presence of 0.4 µM Zn2+ (see insert panel, Fig 37). 
3. 2. B. Ef feet of HEDTA and Zn2+ on Ca2+ transport 
characteristics: 
Apart from the observation that the baseline fluorescence 
was lowered in the presence of a chelator, the time frame 
(t trame l it took for the fluorescence to decrease to the 
baseline value upon the addition of a 20 µM aliquot of Ca2 + 
was retarded (Fig 38B) This suggest that the chelator 
removed an activator, eg. heavy metal ion. This was 
investigated further (Fig 38A). The pump was activated as 
before with ATP and a 20 µM Ca2 + aliquot was added to obtain 
the t frame . 1 µM HEDTA was added, which resulted in a 
fluorescence drop, as was seen previously. Adding the same 
amounts of Zn2+ as in Fig 36, the t frame was increased 3-4 
fold as before. After the addition of total O. 8 µM Zn2+ , a 
steady state fluorescence level was reached. Addition of 
20 µM Ca2+ , led again to an increase in fluorescence, and 
time frame for Ca2+ transport was not retarded as was the 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3. 2. 9. Effect of cd2+, Fe2 + and Cu2 + on Ca2+ transport 
characteristics: 
The Zn2+ effects were also examined with respect to other 
heavy metals, such as Cd2+ , Fe2+ and Cu2+ . The experimental 
protocol is first demonstrated with Zn2+ in Fig 39A, where 
aliquots of Ca2+ are added before and after 1 µM HEDTA 
addition and then after 1 µM of the heavy metal. It can be 
seen that 50 nmoles of Ca2+ is taken up more slowly after 
HEDTA addition and then accelerated back to the original 
speed on the addition of Zn2+ , al though the difference is 
not as pronounced as when the chelator is added prior to the 
addition of ATP (compare Fig 39A with 38B). Rather 
surprisingly very small amounts of Ca2+ appeared to elicit a 
similar effect. Higher concentrations resulted in a huge 
increase in Fluo-3 fluorescence, and obviously Cd2+ 
interacts more strongly with the fluorophore than with the 
chelator. Cu2+ and Fe 2+ caused the baseline fluorescence to 
drop and did not appear to accelerate transport (Fig 40). 
Thus use of heavy metal ions with Fluo-3 and chelators is 
complicated by differing stability constants and firm 
conclusions regarding stimulation of Ca2+ transport cannot 
be drawn, but there is some indication that the effect may 











































































































































































































































































































































In this study two phenomena have been investigated. 
One had to do with the relationship of the catalytic and 
regulatory nucleotide binding site(s) and the role of 
Lys492. It arose from the observation that the quenching 
of TNP-8N3 -AMP superfluorescence by Ca
2 + is retarded if 
the nucleotide is covalently attached to Lys492 through 
light activation of the azido group. It was hoped that a 
comparison of the quench kinetics of mono-, di-, and 
triphospho TNP-nucleotides, tethered and untethered to 
Lys492 could provide some insights into ATP acceleration 
of the steps in the cycle. 
The other phenomenon was an apparent inhibition of the 
pump by low concentrations of EGTA, seemingly enabling 
the pump to generate a greater Ca2+ concentration gradient 
across the SR membrane. It appeared as if the chelator 






the Ca2+-induced quench of 
TNP-nucleotides tethered to 
the 
Lys492 
revealed that increasing the number of phospho groups had 
no effect on the slow kinetics . Neither did altering the 
pH in the range pH 5.5 to 6.5. Quenching the fluorescence 
with EDTA was very fast, too fast in fact for manual 
injection, showing that the step monitored following 
addition of Ca2+ was probably the E2 to E1 transition. The 
kinetics with untethered ( free) TNP-8N3-AMP and TNP-AMP 
were similar and showed an increase in the quench rate 
constant with a rise in pH from 5 . 5 to 6.5. The kinetics 
with the di- and triphospho TNP-nucleotides were 
complicated and suggested utilization of these 
nucleotides as substrates . Use of the nonhydrolysable 
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analogue, TNP-AMP-PCP, failed to elicit acceleration of 
the Ca2+ quench. The E2 to E1 transition is dependent on pH 
(Pick and Karlish, 1982; Froud and Lee, 1986; Wakabayashi 
et al., 1990; Forge et al., 1993). Three H+ are involved 
in the equilibrium in the absence of Ca
2+ ( Forge et al., 
1993) . The kinetics of Ca2+ binding is limited by the 
deprotonation steps (Forge et al., 1993). Mg
2
+ also 
modifies the Ca2+ binding kinetics (Champeil et al., 1983; 
Moutin and Dupont, 1991) and high Mg2+ can induce biphasic 
kinetics by altering the equilibrium in favour of 
deprotonated species producing a mixture of protonated 
and deprotonated forms (Forge et al., 1993). ATP 
accelerates Ca2+ binding (Guillain et al., 1981; Stahl and 
Jencks, 1984; Fernandez-Belda et al., 1984; Wakabayashi 
and Shigekawa, 1990). The effect is pH dependent (Mintz 
et al., 1995). ADP and AMP-PCP increase the rate of Ca
2+ 
binding up to 20-fold at pH 6.0 and change biphasic 
kinetics to a single fast phase at pH 7.0. 
There is an order of magnitude time scale difference 
between the E 2 ~ E 1 transition in our fluorescence 
·experiments and that normally observed for Ca2+ binding at 
pH 6. 0, which is complete within 2 s ( Forge et al., 
1993), whereas 
untethered and 
the Ca2+ quench of superf luorescence of 
tethered TNP-8N3-AMP occurs over 
approximately 50 and 500 s, respectively. This slowness 
can probably be attributed to the presence of glycerol in 
the medium. Glycerol is added to enhance phosphorylation 
and hence superfluorescence (Watanabe and Inesi, 1982). 
Phosphoenzyme decay induced by Ca2+ addition at pH 6.0 or 
6.2 occurs at 0.35 s- 1 ; 0.002 s-1 ; 0.0115 s -1 and 0.035 s-
1 
in aqueous medium, 40% dimethyl sulphoxide, 40% glycerol, 
and 30% dimethyl sulphoxide, respectively (de Meis et 
al• f 1980). The cosolvents probably slow the 
conformational changes associated with the deprotonation 
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events. It can be seen from the pH dependence of the 
quench experiments with tethered nucleotide that the 
ionizations still occur. The very much slower E2 ~ E1 
transition for the tethered nucleotide and its pH 
independence suggest that another conformational change 
is rate limiting here. Tethering TNP-8N3-ATP to Lys492 
accelerates phosphorylation slightly in the forward 
direction of catalysis and partially uncouples the pump 
(McIntosh and Woolley, 1994) . A small nonstoichiometric 
amount of Ca2+ transport is only observed at low pH. These 
findings, together with our fluorescence results, suggest 
that tethering principally effects steps E1P ~ E2P and 
E2 ~ E1 • Perhaps not coincidentally these are the main 
steps accelerated by ATP binding in a regulatory mode. 
Site-directed 
implicated it 
mutagenesis of Lys492 





conformational changes associated with regulation of the 
cycle (McIntosh et al., 1991). There may be a pronounced 
change in the configuration of the nucleotide binding 
site during the E1P ~ E2P and E1 ~ E2 steps. These 
changes in the microenvironment of the nucleotide binding 
site maybe necessary for ATP regulation to take place. 
Tethering TNP-8N3-ATP to Lys492 might inhibit these 
changes and therefore no acceleration of the E1 ~ E2 step 
can occur. Yamamoto et al. ( 198 9) have provided evidence 
through a Ca2+-induced change in conformation around the 
nucleotide binding site as adenosinetriphosphopyridoxal 
(AP3PL) labels Lys492 in EGTA and both Lys684 and Lys492 
in the presence of Ca2+. Thus, the target specificity of 
AP 3 PL changes significantly, but not entirely on Ca
2+ 
binding, so that the spatial arrangement around the 
y-phosphate group of the bound ATP is affected by Ca
2+ 
bound at the transport sites. 
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The E2 intermediates of SR Ca
2+ATPase and Na+K+ATPase have 
different affinities for ATP. Both the E1 and E2 
intermediates of SR Ca2+ATPase display micromolar 
affinity for ATP (Meissner, 1973; Lacapere et al., 1990; 
Wakabayashi et al., 1990). The E2 intermediates of 
Na+K+ATPase have a lower affinity for ATP compared to the 
E1 intermediates (Post et al., 1972, Esmann and Skou, 
1983; Skou and Esmann; 1983; Esman, 1994). However, TNP-
ATP display a higher affinity for the E2 intermediates, as 
it is increased 4-fold by K+ binding, from 0.09 to 0.38 µM 
(Moczydlowski and Fortes, 1981). 
The deocclusion rate constant of Rb+ from the Na+K+ATPase 
E2 .Rb intermediate is accelerated by ATP and ADP, and both 
appear to act at low affinity sites, without 
phosphorylating the enzyme. The difference in ATP 
affinities for the E2 intermediates of SR Ca
2+ATPase and 
Na+K+ATPase, can possibly be explained that the SR 
Ca2+ATPase does not reach an intermediate that is similar 
to the occluded Rb+ intermediate of Na+K+ATPase at low pH. 
However, thapsigargin, a specific inhibitor of Ca2+ATPase, 
binds to the E2 intermediate to form the E2. thapsigargin 
complex. It is possible that this E2 • thapsigargin 
intermediate complex is similar to the occluded form of 
Na+K+ATPase (E2. Rb) . The E2 • thapsigargin intermediate 
complex has a 100-fold lower affinity for ATP, although 
the affinity for TNP-ATP is not affected (DeJesus et al., 
1993; McIntosh et al., 1994). It is · clear that the TNP-
moiety plays a major role in the binding of TNP-ATP to 
the low affinity ATP binding site. TNP-ATP accelerates 
ATP hydrolysis (Dupont et al, 1985) and phosphoenzyme 
hydrolysis (Champeil et al., 1988). However, no 
acceleration of the E2 ~ E1 step was observed. Mintz et 
al (1995) have shown that ADP, AMP-PCP and AMP-PNP 
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accelerate the conformational change E2 ~ E1. The 
deprotonation steps involved in the conformational change 
E2 ~ E1 can be represented in a scheme (Mintz et al., 
1995): 
Scheme 7 




EH ECa r ECa2 ~ 
2H+ Ca2+ 
Ca2+ EHCa 
It is not known which deprotonation step is the slowest 
and accelerated by ATP. It is possible that in the 
presence of glycerol a different slow step prevails, one 
that is not accelerated by ATP . It would be interesting 
to check by direct 45Ca2+ binding measurements using rapid 
filtration whether glycerol eliminates ATP activation of 
the binding kinetics. Alternatively the TNP-nucleotides 
may not accelerate the slow step as ATP does. There does 
not appear to be any report in the literature of TNP-
nucleotides accelerating Ca2+ binding. 
Our results show that the complicated kinetics following 
Ca2+ addition to Ca2+ATPase in the presence of the di- and 
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triphospho TNP-nucleotides can be explained by utiliza-
tion of the nucleotides as substrates in the forward 
direction of catalysis. Hydrolysis of the nucleotides was 
directly demonstrated by monitoring each mono-, di- and 
triphospho species by HPLC. This result contradicts 
previous reports that TNP-ATP is not a substrate of 
Ca2+ATPase (Watanabe and Inesi, 1982; Dupont et al., 
1985). This discrepancy is probably due to the very low 
rate of hydrolysis and suboptimum conditions previously 
used, particularly the pH. It is in agreement with our 
previous study that TNP-8N3-ATP is a well coupled 
substrate of the Ca2+ATPase (McIntosh and Woolley, 1994) . 
Hydrolysis of TNP-ATP by Ca2+ATPase could not be 
unequivocally demonstrated by HPLC analysis as there was 
a significant amount of Ca2+-independent activity that was 
not inhibi table by thapsigargin. However, there was no 
lag in TNP-ATP stimulation of Ca2+ transport or of 
superfluorescence in the forward direction of catalysis, 
suggesting direct activation by the triphosphonucleotide. 
The rate of Ca2+ transport with TNP-ATP and TNP-ADP are 
similar and the lag in the quench of superfluorescence on 
addition of Ca2+ was approximately double with TNP-ATP 
compared to TNP-ADP, again suggesting that the triphospho 
species is utilized directly, followed by the diphospho 
form. Hydrolysis of TNP-ATP in the presence of EGTA or 
thapsigargin is probably catalysed by the small amount of 
myosin contaminating the preparation. Myosin hydrolyses 
TNP-ATP almost as well as ATP (Hiratsuka and Uchida, 
197 3) . The azido species seem to be only hydrolysed by 
the Ca2+ATPase. 
This is the first time that an ADP analogue has been 
found to be a substrate of Ca2+ATPase in the forward 
direction of catalysis. Normally ADP is a substrate in 
the reverse direction, interacting with E1P to form ATP. 
There seem to be no priori or physiological reason why 
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ADP should not also be a substrate in the forward 
direction, unless activation of Ca2+ATPase by reversal of 
the pump is a physiologically important pathway for Ca2+ 
release, which seems not to be the case. Rather it is 
likely that the failure of ADP to act as a substrate is 
due to configuration constraints, exact fitting of the 
substrate into its binding pocket and stabilization 
through binding energy. The structure of a substitution-
inert Co (NH3 ) 4ATP2 at the active site of the homologous 
Na+K+ATPase has been determined by NMR (Stewart and 
Grisham, 1988; Stewart et al., 1989). The molecule adopts 
a U-shape with the phosphates lying parallel to the 
adenine ring. In this way, if the adenine and ribose are 
interacting fairly strongly with their binding site it is 
impossible for the ~-phosphate of ADP to be placed in the 
same position as they-phosphate of ATP. However, if the 
TNP-moiety of TNP-ATP interacts more strongly with 
another pocket such that the adenine and ribose are 
pulled out of position, the ~-phosphate of TNP-ADP may 
align itself with the position normally occupied by the 
y-phosphate of ATP (Fig 41). A site-directed mutagenesis 
study of the amino acids around Lys492 indicates that 
TNP-8N3-ATP and ATP interact in a different way with this 
putative loop (McIntosh et al., 1997). Some amino acid 
mutations that change the affinity for ATP by 1000-fold, 
have no effect on TNP-8N3-ATP affinity. Clearly the TNP-
moiety changes the interaction of the remaining portion 
of the nucleotide with the active site. 
The hydrolysis rate of TNP-8N3-ATP was similar to -ADP, 
15 and 10-12 nmoles/min/mg of protein, respectively. In 
the case of the nonazido derivatives, TNP-ADP was 
hydrolysed twice as fast as -ATP, 10-12 and 
5 nmoles/min/mg of protein, respectively. All four TNP-




























































































































displayed lower transport rates (8-10 nmol/min/mg of 
protein) than their azido derivatives (25 and 
32 nmol/min/mg of protein). The low rate for the nonazido 
nucleotides coupled with apparent tight binding did not 
permit distinction between rates at different nucleotide 
concentrations. The azido nucleotides have an approximate 
Km of 0.5 µM. 
It is interesting to consider whether the true substrate 
of Ca2+ATPase is the protonated or deprotonated TNP-
nucleotide (Scheme 5). The transport assays were 
performed at pH 5.5 and the TNP-nucleotides have a pKa of 
5.1 (Hiratsuka, 1975), which means that 40% of the 
nucleotide will be protonated. Upon protonation, the 
Meissenheimer complex is destroyed and this renders the 
nucleotide nonfluorescent and much more flexible. Our 
results show that, at least in the presence of glycerol, 
a rise in pH from 5. 5 to 6. 5 increase the rate of TNP-
ATP, -ADP, TNP-8N3-ATP and -ADP hydrolysis ( Fig 13 and 
14). This suggests that the unprotonated forms are the 
substrates. However, this pH dependence is opposite to 
that obtained in the absence of glycerol for TNP-8N3-ATP 
(McIntosh and Woolley, 1994) , and the pH dependence of 
hydrolysis may be a poor means of answering this 
question. The tight binding of the TNP species is almost 
certainly due to the Meissenheimer complex as this high 
affinity is observed at alkaline pH. It seems likely that 
the possible forms exhibit a low affinity for the 
Ca2+ATPase and possibly can be discounted as significant 
substrates. 
As mentioned above, TNP-8N3-ATP and TNP-8N3-ADP are 
hydrolysed by Ca2+ATPase with equal facility. Tethering 
TNP-8N3-ATP to Lys492 has been shown to accelerate the 




Caz+ transport can 





at low pH 
TNP-8N3-ADP 
also be utilized as a substrate? The tri-, di-, and mono-
phospho TNP nucleotide label Lys492 with equal ease, 
suggesting that the adenine and TNP-ribose moieties bind 
independently of the phospho groups, and one could 
predict that if the untethered nucleotide are substrates, 
so should the tethered form as well. We obtained no 
evidence in the form of complicated kinetics with the 
tethered nucleotides that they were being utilized as 
substrates. The low levels of EzP that could be generated 
probably renders their detection impossible. It would be 
interesting to test out the hydrolysis of [j3-
3zP] TNP-8N3-
ADP directly. 
The superfluorescence generated in the forward direction 
of catalysis was enhanced in the presence of Pi . This 
superfluorescence enhancement was turnover dependent, as 
it was not observed with the monophospho TNP-nucleotides. 
Therefore, a reasonable explanation is that Ez that is 
generated as a result of enzyme turnover and the slowness 
of the Ez ~ E1 step, reacts with Pi to form the 
superfluorescent EzP species. Quite distinct super-
fluorescence kinetics was observed for the azido and 
nonazido nucleotides under these conditions. These 
differences might be explained by the anti and syn 
configuration of the nonazido and azido nucleotides and 
their different binding affinities for caz+ATPase. 
The other phenomenon investigated was an effect of small 
amounts of EGTA to apparently lower the limiting 
concentration of Caz+ to which the Caz+ATPase can pump 
( [Caz+ ] lirn ) • This effect was observed using Fluo-3 as the 
Caz+ monitoring chromophore 
conditions of transport 
and otherwise under standard 
in the presence of oxalate. 
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Addition of aliquots of Ca2+ 
partially inhibited by the 
showed that 
presence of 
the pump was 
chelator. This 
effect was not unique to EGTA, and chelators EDTA, BAPTA, 
NTA, DTPA and HEDTA all exhibited very similar behaviour 
in lowering [Ca2+] lim with the same Ko.s (0.5 µM) and 
retarding Ca2+ uptake. 
This particular chelator effect appears to be different, 
and yet perhaps related, from a phenomenon previously 
described where at low Ca2+ concentrations, low enough to 
limit pump turnover, CaEGTA appears to activate the pump 
(Berman, 1982). This activation occur when Ca2+ transport 
is measured by a Ca2+-stat method using a Ca2+-electrode 
and Ca2+ infusion. The activation occurs with a 
K0 . 5 (CaEGTA) of 19 µM and is specific for EGTA. This 
effect could be produced with the Fluo-3 system, if Ca2+ 
uptake was measured by statting and infusion (Fig 34). 
Returning to the nonspecific chelator effect of lowering 
[Ca2+Jlim coupled with pump inhibition, it is difficult to 
conceive of a mechanism in which such an effect is 
executed through direct interaction of such diverse 
chelators with the Ca2+ATPase, rather indirect mechanisms 
need to be considered. 
One possibility that we considered was that the ability 
of the pump to apparently increase the Ca2+ gradient is 
due to the increased thermodynamic efficiency (Gafni and 
Boyer, 1985). This requires that less Ca2+ is pumped per 
ATP hydrolysed, i.e. more energy from the latter being 
used to raise the gradient. Gafni and Boyer (1985) 
associated this possibility with a change in stoiciometry 
from 2 to 1 Ca2+ /ATP in going from high to low Ca2+ 
concentrations. Evidence for low Ca2+/ATP stoichiometry 
has been obtained previously with a Ca2+ -electrode stat 
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method (Meltzer and Berman, 1984). There is general 
consensus now that 2 Ca2+ are required for phosphorylation 
by ATP to occur (Jencks, 1982) and any decrease in 
stoichiometry would have to implicate other steps in the 
cycle. While this mechanism remains a possibility it is 
difficult to prove. 
Another possibility that we considered was an effect of 
heavy metal ions. One property which the chelators have 
in common is a very high affinity for heavy metal ions. 
The stability constants of metal ion/ chelator complexes 
Zn2+ r Al 3+, Cd2+, Cu2+, Fe2+ /EGTA, BAPTA, EDTA, NTA, DTPA and 
HEDTA were calculated for our conditions using the 
Fabiato programme (Fabiato and Fabiato, 1973) (Fig 42). 
These complexes are all more stable than Ca2+ or 
Mg2+ / chelator complexes. The values obtained for the Zn2+ 
and Ca2+/chelator complexes are listed in Table 5. 
Table 5 
Apparent stability constants of Zn2 + and Ca2 + chelator 
complexes 
Chelator K (Zn2+chelator) (µM) K (Ca2+chelator) 
EGTA 8.68e+OO 1.03e6 
BAPTA Unknown 9.33e6 
NTA 1.74e+14 5.75e8 
EDTA 9.753e12 1.0le7 
DTPA Unknown 1. 38e5 
HEDTA 3.75e+ll 1.47e5 
It therefore seems possible that at low 
(µM) 
Ca2 + 



















































































































































ions, there may be significant Fluo-3 interaction and the 
addition of low concentrations of chelators could 
preferentially complex the heavy metal ions, lowering the 
chromophore fluorescence and hence the apparent [Ca2+] lim · 
The ability of heavy metal ion/Fluo-3 interaction to 
yield fluorescence was tested directly and, indeed low 
concentrations of Zn2+ produced significant Fluo-3 
fluorescence. Cd2+ seemed particularly effective in this 
regard, although it was not explored in detail. 
Atomic absorption analysis of several SRV preparations 
indicated the presence of Zn2 + at 0.52 nmol/mg of protein, 
or approximately O .1 mol Zn2+ /mol ATPase. At the 
concentration of protein used in the assay medium, this 
translated to a concentration of Zn2+ of O .13 µM. As 
demonstrated, this amount of Zn2 + would account for 
approximately 50% of the fluorescence change produced by 
the addition of chelator under the conditions of the Ca2 + 
uptake assay. It is very likely that SRV are not the only 
source of Zn2+ and/or other heavy metal ions could also be 
present from buffers, cation solutions and potassium 
oxalate. Thus we consider it likely that most of the drop 
in fluorescence on the addition of chelators is due to 
the complexation of heavy metals and the rest due to Ca2+ 
chelation. 
The involvement of heavy metal ions in the observed 
effects is strengthened somewhat by our finding that 
following chelator addition and drop in apparent [Ca2+] um, 
addition of exogenous Zn2+ to bring the baseline 
fluorescence back to the original [Ca2+] um level, results 
in activation of the pump with an aliquot of Ca2+ to the 
original rate. 
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Activation of Ca2+ uptake by Zn2+ would be a puzzle, as 
heavy metal ions are expected to inhibit the pump by 
either binding to the Ca2+ sites or generating sufficient 
ZnATP to compete with MgATP for the active site. It is 
not clear. what steps is rate-limiting under our 
conditions in the presence of oxalate. It is possible it 
is the precipitation of Ca2+oxalate in the vesicle lumen 
or the diffusion of oxalate into the lumen. However it is 
difficult to imagine how small amounts of Zn
2+ could 
facilitate either of these processes in the face of 
millimolar concentrations of oxalate. Oxalate does not 
appear to chelate Zn2+ significantly in the presence of 
5 rnM MgC1 2 as judged from expected Zn
2+ /Fluo-3 fluorescence 
and the amount obtained. Therefore a direct effect of 
heavy metals in facilitating Ca2+ release from the 
Ca2+ATPase to the lumen should be considered. 
The structure of heavy metal binding sites of many 
proteins have been elucidated. Amino acid residues 
cysteine, histidine, aspartic acid and glutamic acid are 
almost always involved. For example, Zn
2+ enzymes, 
Aspartyltranscarbamylase, RNA polymerases, carboxy-
peptidase A, Thermolysin, Alkaline phosphotase, 
Phospholipase C, and Zn2+ containing transcription factors 
all contain clusters of histidine and/ or cysteine 
residues alone or in association with acidic residues 
(Coleman, 1993) Cu2+ATPases from mammals and bacteria 
contain Cu2+ binding motifs on the amino acid terminal 
tail ( Solioz et al., 1994) . They are mostly made up of 
clusters of MTCXSC and MDHSH segments. 
The Ca2+ATPase contains 5 short lumenal loops. The 
sequences of loops 1,2, and 4 are shown in Fig 43. Loop 1 
contains a cluster of 4 glutamates, Loop 2, 2 histidines, 
and Loop 4, 4 histidines, 2 cysteines, and 7 acidic 
residues. The cluster of histidines and cysteines in the 
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latter loop is especially significant and occurs nowhere 
else in the sequence. Three of the histidines are not 
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evidently not essential for Ca2+ transport. It seems 
possible that Loop 4 contains 1-2 heavy metal ion binding 
sites that when occupied accelerate the off rate of Ca2+ 
to the lumen. Membrane helix MS has been implicated in a 
peripheral role in the Ca2+ binding site and M7 is 
considered to be obliquely angled with respect to the 
axis normal to the mebrane (Stokes and Green, 1994). 
Binding of a heavy metal ion in Loop 4 could pull the 
ends together significantly repositioning helix M8 (and 
M7) and facilitating Ca2 + dissociation to the lumen. 
Examination of the effects of other heavy metal ions 
(i.e. Cd2 +, Cu2 + and Fe 2 +) on the chelator phenomonen 
revealed that the assay system is complicated and future 
investigation would be necessary before firm conclusions 
of the Zn2 + ef feet on Ca2+ release can be drawn. In this 
82 
regard it would be interesting to examine the effects of 
Zn2+ and other heavy metal ions on 45Ca2+ release to the 
lumen. However, it would be difficult to distinguish an 
effect on the substrate site from one on the luminal 
sites (Wakabayashi and Shigekawa, 1987). 
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